Western Magnesium (MLYF) 10-Q 14 Jun 22 2022 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Apr. 30, 2022	Jun. 08, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Apr. 30, 2022
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--10-31
Entity File Number	000-56323
Entity Registrant Name	WESTERN MAGNESIUM CORPORATION
Entity Central Index Key	0001801762
Entity Tax Identification Number	61-1934413
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	8180 Greensboro Drive
Entity Address, Address Line Two	Suite 720
Entity Address, City or Town	McLean
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	22102
City Area Code	(571)
Local Phone Number	378-0762
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		443,477,132

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Apr. 30, 2022	Oct. 31, 2021
Current assets
Cash	$ 774,409	$ 462,360
Other receivables	50,765	151,485
Subscription receivable	185,000
Prepayments	119,970	133,647
Deposits held by related parties	388,757	486,462
Total Current assets	1,518,901	1,233,954
Non-current assets
Property, plant and equipment, net	3,977,619	2,574,704
Right-of-use assets, net	469,821	598,575
Mineral property costs	93,453	93,453
Reclamation and other deposits	12,736	1
Deferred costs	2,973
TOTAL ASSETS	6,075,503	4,513,512
Current liabilities
Accounts payable and accrued liabilities	2,715,924	1,989,316
Due to related parties	1,253,280	1,026,817
Lease obligations – current	244,592	192,045
Provision for flow through share issuances	225,833	233,285
Convertible debenture, net	1,783,584	7,449,807
Warrant liability	2,468,261
Total Current liabilities	8,691,474	10,891,270
Non-current liabilities
Lease obligations – non-current	254,147	392,280
Total liabilities	8,945,621	11,283,550
Commitments and contingencies [note 9]
Shareholders’ deficit
Capital stock Authorized: 1 billion common stock at par value of $0.001 Issued and paid: 434,866,801 (2021 – 392,943,398)	39,096,950	29,842,167
Additional paid-in-capital	23,204,066	15,186,480
Obligations to issue shares	388,701	209,827
Accumulated other comprehensive income	335,072	121,109
Accumulated deficit	(65,894,907)	(52,129,621)
Total shareholders’ deficit	(2,870,118)	(6,770,038)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	$ 6,075,503	$ 4,513,512

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical)	Apr. 30, 2022$ / sharesshares	Oct. 31, 2021$ / sharesshares
Statement of Financial Position [Abstract]
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, par value | (per share)	$ 0.001	$ 0.001
Common stock, shares issued	434,866,801	392,943,398
Common stock, shares outstanding	434,866,801	392,943,398

Condensed Consolidated Statemen

Condensed Consolidated Statements of Loss and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2022	Apr. 30, 2021
Operating expenses (recoveries)
Bank charges	$ 5,388	$ 3,591	$ 8,652	$ 6,154
Business development	31,777		77,329
Computer system and software	27,703	11,697	39,354	71,785
Consulting and management fees	215,709	271,853	413,636	338,954
Depreciation	132,987	45,666	242,327	96,993
Due diligence expenses		1,964		1,964
Engineering expenses (recoveries)	(1,565)	119,066	116,808	55,454
Foreign exchange loss (gain)	58,661	(152,518)	226,135	(86,227)
Interest and accretion	326,868	17,760	649,148	36,334
Investor relations	109,456	19,060	215,834	70,936
Legal and professional fees	970,206	263,841	1,577,054	287,586
Office and general	21,278	22,158	77,358	59,611
Facilities and rent	112,452	70,190	176,121	85,275
Salaries and benefits	1,201,297	631,284	2,196,839	1,366,932
Stock-based compensation	302,254	(1,060,085)	433,829
Shareholder communications	7,500	86,234	40,701	86,234
Subsidies and recoveries	(48,117)	(41,247)	(79,219)	(41,247)
Transfer agent and regulatory fees	65,720	14,747	88,737	23,630
Travel expenses	137,827	109,839	221,943	110,676
Total operating expenses	3,677,401	435,100	6,722,586	2,571,044
Other income (expense)
Change in fair value of derivative liability	4,858,644	31,190	(6,701,147)	16,656
Loss on recognition of debt host liability			(341,553)
Total other income (expense), net	4,858,644	31,190	(7,042,700)	16,656
Net income (loss)	1,181,243	(403,910)	(13,765,286)	(2,554,388)
Other comprehensive income (loss)
Foreign currency translation	49,183	(114,645)	213,963	(191,049)
Comprehensive income (loss)	$ 1,230,426	$ (518,555)	$ (13,551,323)	$ (2,745,438)
Basic and diluted income (loss) per common share	$ 0	$ 0	$ (0.03)	$ (0.01)
Weighted average number of common shares outstanding – basic and diluted	425,430,900	344,627,567	443,272,627	330,018,463

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Shareholders' Deficit - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Obligation to issue shares [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Oct. 31, 2020	$ 21,322,022	$ 4,182,037	$ 596,872	$ 399,175	$ (28,580,009)	$ (2,079,903)
Beginning balance, shares at Oct. 31, 2020	323,419,527
Shares issued pursuant to private placements [note 13[b]]	$ 2,621,314		(596,872)			2,024,442
Shares issued pursuant to private placements [note 13[b]], shares	25,724,955
Shares issued on warrants exercised [notes 12[f] and 13[b]]	$ 16,113					16,113
Shares issued on warrants exercised [notes 12[f] and 13[b]], shares	400,000
Shares issued on options exercised [note 13[b]]	$ 4,002					4,002
Shares issued on options exercised [note 13[b]], shares	100,000
Share subscriptions [note 13[f]]			45,446			45,446
Share issue costs [note 13[b]]	(194,584)					(194,584)
Foreign currency translation				(191,049)		(191,049)
Net loss for the period					(2,554,388)	(2,554,388)
Ending balance, value at Apr. 30, 2021	$ 23,768,867	4,182,037	45,446	208,126	(31,134,397)	(2,929,921)
Ending balance, shares at Apr. 30, 2021	349,644,482
Beginning balance, value at Oct. 31, 2021	$ 29,842,167	15,186,480	209,827	121,109	(52,129,621)	(6,770,038)
Beginning balance, shares at Oct. 31, 2021	392,943,398
Shares issued pursuant to private placements [note 13[b]]	$ 756,524		(209,827)			546,697
Shares issued pursuant to private placements [note 13[b]], shares	1,375,499
Shares issued on warrants exercised [notes 12[f] and 13[b]]	$ 7,794,624					7,794,624
Shares issued on warrants exercised [notes 12[f] and 13[b]], shares	23,701,146
Shares issued on options exercised [note 13[b]]	$ 51,918	(22,203)				29,715
Shares issued on options exercised [note 13[b]], shares	750,000
Share subscriptions [note 13[f]]			388,701			388,701
Share issue costs [note 13[b]]	(36,461)					(36,461)
Foreign currency translation				213,963		213,963
Net loss for the period					(13,765,286)	(13,765,286)
Shares issued upon conversion of convertible debenture [notes 12[b], 12[c] and 13[b]]	$ 688,178					688,178
Shares issued upon conversion of convertible debenture [notes 12[b], 12[c] and 13[b]], shares	6,933,333
Shares issued for finder’s fees [note 13[b]]
Shares issued for finder's fees [note 13[b]], shares	9,163,425
Stock-based compensation [note 13[d]]		433,829				433,829
Beneficial conversion feature on convertible debentures [note 12[d]]		240,000				240,000
Effects of change in functional currency on convertible debentures [note 12[e]]		7,370,158				7,370,158
Effects of change in functional currency on broker warrants [note 12[f]]		(4,198)				(4,198)
Ending balance, value at Apr. 30, 2022	$ 39,096,950	$ 23,204,066	$ 388,701	$ 335,072	$ (65,894,907)	$ (2,870,118)
Ending balance, shares at Apr. 30, 2022	434,866,801

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2022	Apr. 30, 2021	Oct. 31, 2021
OPERATING ACTIVITIES
Net loss	$ 1,181,243	$ (403,910)	$ (13,765,286)	$ (2,554,388)
Adjustments to reconcile net loss to net cash used in operating activities:
Accrued interest and accretion			50,819	21,317
Amortization of debt discount			600,771
Change in fair value of derivative liability	(4,858,644)	(31,190)	6,701,147	(16,656)
Loss on recognition of debt host liability			341,553
Depreciation of property, plant and equipment			123,961	8,645	$ 44,148
Depreciation of right-of-use assets			118,366	88,348	185,754
Foreign exchange loss			204,106	73,637
Interest expense on lease obligations			17,897	10,821
Stock-based compensation	302,254	(1,060,085)	433,829
Cashless warrant exercise			(113,765)
Changes in operating assets and liabilities:
Other receivables			96,860	(58,815)
Prepayments			9,509	(23,000)
Deposits held by related parties			83,022	(235,682)
Accounts payable and accrued liabilities			798,064	1,114,588
Due to related parties			261,840	294,115
Cash used in operating activities			(4,037,307)	(1,335,724)
INVESTING ACTIVITIES
Purchase of property, plant and equipment			(1,601,999)	(397,869)
Cash used in investing activities			(1,601,999)	(397,869)
FINANCING ACTIVITIES
Proceeds from issuance of shares, net of share issuance costs			3,851,614	1,856,336
Deferred financing costs			(2,973)	(25,179)
Proceeds from share subscriptions			203,701	45,446
Proceeds from convertible debenture			2,000,000	78,566
Payments of promissory note				(64,993)
Payments of lease obligations			(93,244)	(99,573)
Cash provided by financing activities			5,959,098	1,790,603
Change in cash for the period			319,792	57,010
Cash, beginning of the period			462,360	39,571	39,571
Effect of foreign exchange on cash			(7,743)	(26,216)
Cash, end of the period	$ 774,409	$ 70,365	774,409	70,365	$ 462,360
Other non-cash transactions:
Shares issued for conversion of debt and interest			688,178
Shares issued for payment of finder’s fees			4,796,832
Other cash flow disclosures:
Cash paid during the period for interest			$ 5,549

NATURE OF OPERATIONS AND GOING

NATURE OF OPERATIONS AND GOING CONCERN	6 Months Ended
	Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS AND GOING CONCERN	1. NATURE OF OPERATIONS AND GOING CONCERN Western Magnesium Corporation (the “Company”, or “WMC”) was incorporated under the laws of British Columbia on March 24, 1966. On May 14, 2019, the Company discontinued from the jurisdiction of the Business Corporations Act (British Columbia) and domesticated under the General Corporation Law of the State of Delaware under the name “Western Magnesium Corporation”. The Company is a reporting issuer in Canada and in the United States, listed for trading in Canada on the TSX Venture Exchange (the “TSX-V”) under the symbol “WMG.V”, in the United States on the OTCQB tier of the OTC Markets (the “OTCQB”) under the symbol “MLYF”, and in Germany on the Frankfurt Stock Exchange under the symbol “3WM”. The Company has developed proprietary magnesium production technology with the aim of becoming a premier low-cost producer of green primary magnesium metal. As at April 30, 2022, the Company had an accumulated deficit of $ 65,894,907 (October 31, 2021 – $ 52,129,621 ) and working capital deficiency of $ 7,172,573 (October 31, 2021 – $ 9,657,316 ). For the six months ended April 30, 2022, the Company reported a comprehensive loss of $ 13,551,323 (2021 – $ 2,745,438 ). The Company has not yet achieved profitable operations and expects to incur further losses from operations. The Company has financed its activities and operations through equity issuances and debt financing and expects to continue to do so to the extent such financing is available. There can be no assurance that such financing will be available under terms acceptable to the Company or at all. These unaudited condensed consolidated financial statements (the “Financial Statements”) have been prepared under the assumption that the Company will continue as a going concern. The going concern basis of presentation assumes that the Company will be able to meet its obligations and continue its operations for the foreseeable future and be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Management believes that the going concern assumption is appropriate for these Financial Statements based on its continuing ability to raise financings through share and debt issuances. If future financing is unavailable or if for any reason the Company is unable to continue as a going concern, it could impact the Company’s ability to realize its assets at their recognized values and to meet its obligations in the ordinary course of business at the amounts stated in these Financial Statements. These Financial Statements do not give effect to adjustments that would be necessary to the carrying values and classifications of assets and liabilities should the Company be unable to continue as a going concern. If the going concern assumption is not used, the adjustments required to report the Company’s assets and liabilities on a liquidation basis could be material to these Financial Statements. The Company’s management has evaluated whether there is substantial doubt about the Company’s ability to continue as a going concern and has determined that substantial doubt existed as of April 30, 2022. This determination was based on the following factors: (i) the Company used cash of approximately $ 4.0 million in operations during the six months ended April 30, 2022; (ii) the Company’s available cash as of April 30, 2022 will not be sufficient to fund its anticipated level of operations for the next 12 months; (iii) the Company will require additional financing for the fiscal year ending October 31, 2022 to continue at its expected level of operations; and (iv) if the Company fails to obtain the needed capital, it will be forced to delay, scale back, or eliminate some or all of its development activities or perhaps cease operations. In the opinion of management, these factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for at least one year from the date of these Financial Statements are issued. In March 2020, the World Health Organization declared COVID-19 a global pandemic. In order to combat the spread of COVID-19, governments worldwide, including the Unites States and Canada, have enacted emergency measures including travel bans, legally enforced or self-imposed quarantine periods, social distancing and business and organization closures. These measures have adversely affected workforces, economies, and financial markets globally, leading to an economic downturn. The impact on the Company has not been significant but could affect the Company’s ability to raise financings in the future and restrict travel. Management continues to monitor the situation.

BASIS OF PRESENTATION

BASIS OF PRESENTATION	6 Months Ended
	Apr. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	2. BASIS OF PRESENTATION These Financial Statements comprise the financial statements of Western Magnesium Corporation and its wholly owned subsidiaries, Western Magnesium Corp., incorporated in Nevada, United States and Western Magnesium Canada Corporation, incorporated in British Columbia, Canada. [a] Accounting standards The accompanying Financial Statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) on the basis that the Company will continue as a going concern, which assumes that the Company will be able to meet its obligations as they become due and continue its operations for at least one year from the date these Financial Statements are issued. Realization values may be substantially different from carrying values as shown and these Financial Statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. These Financial Statements have been prepared on a historical cost basis except for financial instruments that have been measured at fair value. In addition, these Financial Statements have been prepared using the accrual basis of accounting, except for cash flow information. They do not include all the information required for complete annual financial statements and should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended October 31, 2021 (the “Fiscal 2021 Financial Statements”). [b] Functional and presentation currency These Financial Statements are presented in United States dollars (“US dollars” or “US$”), except where otherwise indicated. The functional currency of each entity of the Company is as follows: Entity Functional Currency Western Magnesium Corporation United States dollars Western Magnesium Corp. United States dollars Western Magnesium Canada Corporation Canadian dollars (“CA$”) During the three months ended January 31, 2022, significant changes in economic facts and circumstances have occurred in Western Magnesium Corporation’s operations which resulted in the change of its functional currency to the United States dollars from the Canadian dollar effective November 1, 2021. For both monetary and non-monetary assets and liabilities, translated balances at the end of the prior period become the new accounting basis. The rate on the date of change becomes the historical rate at which non-monetary assets and liabilities are translated in subsequent years. There is no effect on the cumulative translation adjustment on the consolidated basis. Previously recorded cumulative translation adjustments are not reversed. Effects of change in functional currency included the reclassifications of convertible debentures and warrants and broker warrants [notes 12[d] and [e]] The accounts of the Company’s subsidiary Western Magnesium Canada Corporation have been translated to United States dollars with the exchange translation adjustments recorded in other comprehensive income (loss). [c] Critical accounting estimates and judgments Significant Estimates and Assumptions The preparation of these Financial Statements in accordance with US GAAP requires the Company to make estimates and assumptions concerning the future that affect the amounts reported in the Financial Statements and accompanying notes. Management reviews these estimates and underlying assumptions on an ongoing basis, based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are adjusted for prospectively in the period in which the estimates are revised. Estimates and assumptions where there is potential risk of material adjustments to assets and liabilities in future accounting periods include the useful lives of property, plant and equipment, recoverability of the carrying value of exploration and evaluation assets, fair value measurements for financial instruments, discount rates for leases, recoverability and measurement of deferred tax assets and liabilities, and contingent liabilities. Significant Judgments The preparation of these Financial Statements in accordance with US GAAP requires the Company to make judgments, apart from those involving estimates, in applying accounting policies. The most significant judgments in applying the Company’s Financial Statements include: - the assessment of the Company’s ability to continue as a going concern and whether there are events or conditions that may give rise to substantial doubt; - whether there are indicators of impairment of the Company’s exploration and evaluation assets and other non-current assets; - the classification of financial instruments; and - determination of functional currency.

RECENT ACCOUNTING PRONOUNCEMENT

RECENT ACCOUNTING PRONOUNCEMENTS	6 Months Ended
	Apr. 30, 2022
Accounting Changes and Error Corrections [Abstract]
RECENT ACCOUNTING PRONOUNCEMENTS	3. RECENT ACCOUNTING PRONOUNCEMENTS New Accounting Standards Adopted During the Periods In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. Effective November 1, 2021, the Company adopted the new standard. There was no material impact or adjustment to these Financial Statements. In January 2020, the FASB issued ASU 2020-01, Investments – Equity Securities (Topic 321), Investments – Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (“ASU 2020-01”), which is intended to clarify the interactions of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, with early adoption permitted. Effective November 1, 2021, the Company adopted the new standard. There was no material impact or adjustment to these Financial Statements. New Accounting Standards Not Yet Adopted In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”). ASU 2020-06 eliminates the beneficial conversion and cash conversion accounting models for convertible instruments and supersedes the respective guidance within ASC 470-20 and ASC 740-10-55-51, which will result in more instruments to be accounted for as a single instrument rather than having their proceeds allocated between liability and equity accounting units. As smaller reporting companies as defined by the United States Securities and Exchange Commission (the “SEC”), ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effect this standard will have on its Financial Statements.

PROPERTY, PLANT AND EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT	6 Months Ended
	Apr. 30, 2022
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT	4. PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT Computer Equipment Furniture Leasehold Improvement Furnace & Plant Equipment Vehicle Total $ $ $ $ $ $ Cost Balance, October 31, 2020 32,318 38,916 7,610 28,413 – 107,257 Additions 77,955 11,510 129,257 2,278,205 – 2,496,927 Write-off of equipment (4,245 ) – – – – (4,245 ) Foreign exchange effect 3,601 3,116 2,614 38,108 – 47,439 Balance, October 31, 2021 109,629 53,542 139,481 2,344,726 – 2,647,378 Additions 7,008 2,171 107,014 1,456,591 29,215 1,601,999 Foreign exchange effect – (288 ) (5,306 ) (70,509 ) (302 ) (76,405 ) Balance, April 30, 2022 116,637 55,425 241,189 3,730,808 28,913 4,172,972 Accumulated Depreciation Balance, October 31, 2020 14,677 8,326 4,818 – – 27,821 Depreciation expense 13,907 7,443 8,827 13,971 – 44,148 Write-off of equipment (2,057 ) – – – – (2,057 ) Foreign exchange effect 1,294 745 502 221 – 2,762 Balance, October 31, 2021 27,821 16,514 14,147 14,192 – 72,674 Depreciation expense 18,236 3,833 15,217 83,755 2,920 123,961 Foreign exchange effect – (48 ) (404 ) (801 ) (29 ) (1,282 ) Balance, April 30, 2022 46,057 20,299 28,960 97,146 2,891 195,353 Net Book Value Balance, October 31, 2020 17,641 30,590 2,792 28,413 – 79,436 Balance, October 31, 2021 81,808 37,028 125,334 2,330,534 – 2,574,704 Balance, April 30, 2022 70,580 35,126 212,229 3,633,662 26,022 3,977,619

RIGHT-OF-USE ASSETS

RIGHT-OF-USE ASSETS	6 Months Ended
	Apr. 30, 2022
Right-of-use Assets
RIGHT-OF-USE ASSETS	5. RIGHT-OF-USE ASSETS As at April 30, 2022, the right-of-use assets are leases for the Company’s offices in Vancouver, British Columbia and McLean, Virginia, and its research and development pilot plant located in Burnaby, British Columbia. These leases terminate on March 31, 2023, February 28, 2025 and September 30, 2023, respectively. The lease for the Company’s office in Las Vegas, Nevada ended on May 31, 2021. SCHEDULE OF RIGHT- OF - USE ASSETS Vancouver Office Virginia Office Nevada Office Pilot Plant Total $ $ $ $ $ Cost Balance, October 31, 2020 59,701 – 22,856 357,949 440,506 Additions 91,237 287,847 – – 379,084 Foreign exchange effect 5,943 4,544 1,724 26,997 39,208 Balance, October 31, 2021 156,881 292,391 24,580 384,946 858,798 Foreign exchange effect – (3,038 ) – (12,278 ) (15,316 ) Balance, April 30, 2022 156,881 289,353 24,580 372,668 843,482 Accumulated Depreciation Balance, October 31, 2020 42,142 – 14,434 9,943 66,519 Depreciation expense 44,259 15,288 8,915 117,292 185,754 Foreign exchange effect 3,876 241 1,231 2,602 7,950 Balance, October 31, 2021 90,277 15,529 24,580 129,837 260,223 Depreciation expense 22,229 33,790 – 62,347 118,366 Foreign exchange effect – (162 ) – (4,766 ) (4,928 ) Balance, April 30, 2022 112,506 49,157 24,580 187,418 373,661 Net Book Value Balance, October 31, 2020 17,559 – 8,422 348,006 373,987 Balance, October 31, 2021 66,604 276,862 – 255,109 598,575 Balance, April 30, 2022 44,375 240,196 – 185,250 469,821

LEASE OBLIGATIONS

LEASE OBLIGATIONS	6 Months Ended
	Apr. 30, 2022
Lease Obligations
LEASE OBLIGATIONS	6. LEASE OBLIGATIONS On adoption of ASU 2016-02 on November 1, 2019, the Company recognized lease liabilities of $ 83,549 7% During the year ended October 31, 2020, the Company entered into a new operating lease with respect to its research and development pilot plant located in Burnaby, British Columbia and recognized a lease liability of $ 354,263 6% During the year ended October 31, 2021, the Company renewed its operating lease with respect to its office in Vancouver, British Columbia and recognized a lease liability of $ 91,237 7% During the year ended October 31, 2021, the Company entered into a new operating lease with respect to its corporate head office in McLean, Virginia and recognized a lease liability of $ 260,649 7% SCHEDULE OF OPERATING LEASE Vancouver Office Virginia Office Nevada Office Pilot Plant Total $ $ $ $ $ Balance, October 31, 2020 18,123 – 12,211 350,593 380,927 Additions 91,237 260,649 – – 351,886 Lease payments (47,931 ) (5,137 ) (9,457 ) (139,037 ) (201,562 ) Interest expense 3,076 3,019 219 19,005 25,319 Prior period adjustment – – (3,065 ) – (3,065 ) Foreign exchange effect 2,099 4,081 92 24,548 30,820 Balance, October 31, 2021 66,604 262,612 – 255,109 584,325 Lease payments (24,187 ) – – (69,057 ) (93,244 ) Interest expense 1,958 9,230 – 6,711 17,899 Foreign exchange effect – (2,728 ) – (7,513 ) (10,241 ) Balance, April 30, 2022 44,375 269,114 – 185,250 498,739 Which consist of: Current lease obligation 44,375 71,092 – 129,125 244,592 Non-current lease obligation – 198,022 – 56,125 254,147 Balance, April 30, 2022 44,375 269,114 – 185,250 498,739

MINERAL PROPERTY COSTS

MINERAL PROPERTY COSTS	6 Months Ended
	Apr. 30, 2022
Extractive Industries [Abstract]
MINERAL PROPERTY COSTS	7. MINERAL PROPERTY COSTS As at April 30, 2022, the Company had the following mining claims: [a] Silverado Property Nevada, United States The Silverado property is located in the Pinto mining district of Nevada, consists of 3 patented mining claims totaling approximately 120 100 1 [b] Tami Mosi Property, Nevada, United States The Company holds a 100 1,637 10 2 93,452

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Apr. 30, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	8. RELATED PARTY TRANSACTIONS [a] Deposits held by related parties The Company provided related parties with advances that were held as deposits for anticipated future costs related to the Company’s planned magnesium research and development pilot plant and other administrative expenses (the “Pilot Plant Advances”). As at April 30, 2022, the Company had the following deposits held by related parties: SCHEDULE OF DEPOSITS HELD BY RELATED PARTY Related Party A [i] Related Party B [ii] Total $ $ $ Balance, October 31, 2020 – – – Advances 987,912 2,292,912 3,280,824 Costs and expenses (696,431 ) (2,097,931 ) (2,794,362 ) Balance, October 31, 2021 291,481 194,981 486,462 Advances 330,930 1,225,118 1,556,048 Costs and expenses (249,872 ) (1,420,829 ) (1,670,701 ) Foreign exchange effect 16,218 730 16,948 Balance, April 30, 2022 388,757 – 388,757 [i] Related Party A is a company controlled by a director and officer. [ii] Related Party B is a company controlled by an officer. [b] Due to related parties As at April 30, 2022, balances due to related parties totaled $ 1,253,280 1,026,817 SCHEDULE OF DUE TO RELATED PARTIES April 30, 2022 October 31, $ $ Wages payable to directors and officers 357,500 357,500 Benefits payable to directors and officers 730,810 539,209 Fees and expenses payable to directors and officers 164,970 127,878 Interest due to a shareholder – 2,230 Total 1,253,280 1,026,817 [c] Key management compensation As at April 30, 2022, the Company had twelve executives including seven key senior management members. Their aggregate annualized compensation is approximately $ 3.1 1,626,279 160,700 [d] Transactions with related parties [i] During the six months ended April 30, 2022, the Company incurred consulting fees of $ 27,630 35,000 [ii] During the six months ended April 30, 2022, the Company incurred consulting fees of $ 30,000 [iii] In June 2021, the Company renewed its sublease agreement with a company controlled by a director and officer for its office in Vancouver, British Columbia with a lease term from April 1, 2021 to March 31, 2023 7,656 9,794 [iv] Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by a director and officer is eligible to receive up to 5 5 9,163,425 0.65 4,796,832 5,956,226

CONTINGENT LIABILITIES AND COMM

CONTINGENT LIABILITIES AND COMMITMENTS	6 Months Ended
	Apr. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
CONTINGENT LIABILITIES AND COMMITMENTS	9. CONTINGENT LIABILITIES AND COMMITMENTS [a] Contingent liabilities [i] On September 29, 2020, James Sever filed a Notice of Civil Claim against the Company in the Supreme Court of British Columbia (the “Sever Claim”). The Sever Claim alleges that Mr. Sever had an employment and/or other similar contractual relationship with the Company, and that the Company breached such contractual relationship by way of constructive dismissal or similar conduct. The Sever Claim seeks damages in excess of $ 2.5 million, certain equity compensation, prejudgment garnishment, costs, interest and other non-monetary relief. On July 27, 2021, the Company filed a response to the Sever Claim. On April 5, 2022, the Company filed an amended response to the Sever Claim, which included the following pleadings: (a) British Columbia is an inappropriate and inconvenient forum for the Sever Claim; (b) to the extent that British Columbia is the appropriate forum for the Sever Claim, nonetheless: (i) the Sever Claim is barred in whole or in part by applicable doctrines of delay / statute of limitations, (ii) the Company did not constructively dismiss Mr. Sever and, instead, it was Mr. Sever that abandoned, quit or resigned from his obligations to the Company, (iii) the Company has no debts, liabilities or obligations to Mr. Sever. The Company intends to vigorously defend against the Sever Claim, and believes that the Sever Claim is without merit. As the Company cannot predict the outcome of the Sever Claim, no provision has been recognized as there is no present obligation and the probability of an outcome cannot be determined. [ii] On December 31, 2020, GEM Yield Bahamas Limited (“GEM”) served the Company with a Notice of Intention to Arbitrate (the “New York Arbitration Notice”) before the American Arbitration Association in New York (the “GEM New York Arbitration”). The New York Arbitration Notice alleges the Company breached a Share Subscription Agreement dated November 15, 2019 entered into between the Company and GEM (the “GEM Agreement”), among other things, claiming damages of approximately $ 3.4 million (CA$ 4.2 million). On January 19, 2021, the Company filed a petition in the New York Supreme Court to stay the GEM New York Arbitration claiming the GEM Agreement was not valid. On March 19, 2021, the Court in the New York State Action ruled that there was an arbitration clause in the GEM Agreement but it was up to the arbitrator to determine if the arbitration clause was valid. Following this ruling, the New York State Action was closed. In June 2021, GEM filed a Statement of Claim in the GEM New York Arbitration, and the Company filed a Statement of Answer denying the existence of any binding agreement between the Company and GEM, among other defenses. In January 2022, the Company filed a Modified Statement of Defense and Counterclaims. On April 8, 2022, the parties agreed to consolidate this arbitration with the GEM Montreal Arbitration. The parties then filed consolidated pleadings, and both matters will be decided via arbitration in Montreal. The Company intends to vigorously defend itself in the GEM New York Arbitration and believes the allegations lack merit. As the Company cannot predict the outcome of this arbitration proceeding, no provision has been recognized in respect to the GEM New York Arbitration as there is no present obligation and the probability of an outcome cannot be determined. [iii] On February 8, 2021, GEM instituted another arbitration against the Company before the International Centre for Dispute Resolution in Montreal Canada (the “GEM Montreal Arbitration”) and joined GEM’s affiliate, GEM Global Yield LLC SCS (“GEM Global Yield” together with GEM, the “GEM Parties”). The Statement of Claim filed by the GEM Parties alleges the Company breached a Share Subscription Agreement dated November 15, 2019 and promissory note, among other things, claiming damages of approximately $ 3.9 million (CA$ 4.9 million), in addition to costs and expenses, stemming from the Company’s alleged failure to issue to GEM Global Yield warrants to purchase up to 33 million shares of the Company’s common stock. The Company filed a Statement of Defense denying the existence of any binding agreement between the Company and GEM, among other defenses. In January 2022, the Company filed an Amended Statement of Defense and Cross-claim. On April 8, 2022, the parties agreed to consolidate this arbitration with the GEM New York Arbitration. The parties then filed consolidated pleadings, and both matters will be decided via arbitration in Montreal. The Company intends to vigorously defend itself in the GEM Montreal Arbitration and believes the allegations lack merit. As the Company cannot predict the outcome of this arbitration proceeding, no provision has been recognized in respect to the GEM Montreal Arbitration as there is no present obligation and the probability of an outcome cannot be determined. [iv] On April 19, 2021, Lampert Advisors, LLC (“Lampert”) filed a Verified Complaint against the Company’s wholly owned subsidiary Western Magnesium Corp., a Nevada corporation (“Western Magnesium – Nevada”) in the Supreme Court of the State of New York, County of New York (the “Lampert Lawsuit”). The complaint filed in the Lampert Lawsuit alleges that Lampert entered into an agreement with Western Magnesium – Nevada to provide various financial advisory services including acquisition advisory services and act as an exclusive placement agent for a combination of debt and equity securities (the “Lampert Agreement”), that it performed all services required under that agreement and that it is owed $ 367,227 plus interest at the rate of 9 % from February 3, 2021 and that it has a right of first refusal to act as financial advisor in connection with any debt, equity or debt restructuring assignments on terms, conditions and compensation customary for Lampert for a transaction of the type contemplated. Although Lampert claims to have personally served Western Magnesium – Nevada, the Company never received the Summons and Complaint and therefore, never submitted a response. On September 9, 2021, Lampert filed a Motion seeking the entry of a default judgment (the “Motion”). The Company opposed the Motion and filed a cross-motion to compel Lampert to accept the Company’s answer. The Court granted the Company’s cross-motion and denied Lampert’s Motion as moot. On March 4, 2022, the Company filed a Verified Amended Answer, Affirmative Defenses, and Counterclaims. The counterclaims seek at least $ 120,000 [b] Commitments [i] On November 1, 2016, the Company signed a contract services agreement with Lodestar Management Group, LLC (“Lodestar”), a US corporate logistics company. Lodestar provides advisory, consulting, negotiation and other management services relating to corporate management, administrative and/or operational activities of the Company. The term of the contract was for one year and has been renewed under the same terms on January 1, 2018 and 2019. The Company has agreed to compensate Lodestar in the amount of $ 1,800 2,500 0.05 1,800 2,500 30,624 nil nil 32,716 53,491 [ii] During the year ended October 31, 2020, the Company has entered into a lease agreement for its research and development pilot plant in Burnaby, British Columbia with a lease term from October 1, 2020 to September 30, 2023 at a monthly rent of $ 16,194 (CA$ 20,715 ). In June 2021, the Company renewed its sublease agreement with a company controlled by a director and officer for its office in Vancouver, British Columbia with a lease term from April 1, 2021 to March 31, 2023 at a monthly rent of $ 7,656 (CA$ 9,794 ). In September 2021, the Company entered into a lease agreement for its corporate head office in McLean, Virginia with a lease term from September 14, 2021 to February 28, 2025 at a monthly rent of $ 9,113 . The Company will be abated for the first five months and is entitled to a tenant allowance of $ 41,010 [notes 5 and 6]

PROMISSORY NOTE

PROMISSORY NOTE	6 Months Ended
	Apr. 30, 2022
Promissory Note
PROMISSORY NOTE	10. PROMISSORY NOTE During the year ended October 31, 2019, the Company received a loan of $ 112,895 150,000 18 44,588 60,000 157,483 210,000 September 24, 2021 1,639 16,655 65,761 101,066

PROVISION FOR FLOW THROUGH SHAR

PROVISION FOR FLOW THROUGH SHARE ISSUANCES	6 Months Ended
	Apr. 30, 2022
Provision For Flow Through Share Issuances
PROVISION FOR FLOW THROUGH SHARE ISSUANCES	11. PROVISION FOR FLOW THROUGH SHARE ISSUANCES The Company has recorded a provision in the amount of $ 225,833 233,285

CONVERTIBLE DEBENTURE AND DERIV

CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY	6 Months Ended
	Apr. 30, 2022
Debt Disclosure [Abstract]
CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY	12. CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY [a] July 2020 Convertible Debenture On July 27, 2020, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of $ 112,124 150,000 12 0.15 1,360,959 263,973 26,286 37 [b] July 2021 Convertible Debenture On July 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of $ 79,542 100,000 12 0.12 0.20 933,333 594% [c] June 2021 Convertible Debenture On June 15, 2021, the Company closed a non-brokered private placement of an unsecured convertible note in the principal amount of $ 1,500,000 12 December 10, 2022 15,000,000 (i) one share of the Company’ common stock, (ii) one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being exercisable at a price of $0.19 until June 10, 2026 (collectively, the “Class A and B Warrants”). In addition, the conversion price for accrued interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSX-V at the time of conversion As part of the offering of the June 2021 Convertible Debenture, the Company also entered into a securities purchase agreement dated June 10, 2021 (the “2021 Securities Purchase Agreement”), whereby the Company agreed to use commercially reasonable efforts to file a registration statement with the United States Securities and Exchange Commission (the “SEC”) by August 14, 2021, covering the public resale of the shares of common stock underlying such debenture and, upon its conversion, the Class A and B Warrants issuable upon such conversion (the “Underlying Shares”), and to use its best efforts to cause the registration statement to be declared effective on October 13, 2021. On December 13, 2021, the Company’s Form 10 Registration Statement filed with the SEC was declared effective. In addition to certain covenants contained in the 2021 Securities Purchase Agreement, the terms of the June 2021 Convertible Debenture contain certain negative covenants by the Company, including, among others, sell or offer to sell any securities with non-fixed or floating price features, issue any common stock or common stock equivalents at a price lower than the conversion price herein then in effect, or issue any equity or debt instruments with anti-dilution provisions. In the event the Company issues or sells any common stock or common stock equivalents with terms that the purchaser holding the outstanding June 2021 Convertible Debenture or the Class A and B Warrants reasonably believes are more favorable to such holder than the terms of the June 2021 Convertible Debenture or the Class A and B Warrants, then upon notice to the Company by such holder within five trading days after notice to such holder by the Company, the Company will use commercially reasonable efforts to obtain the approval of the TSX-V and any additional required regulatory approval to amend the terms of the June 2021 Convertible Debenture or the Class A and B Warrants as required, as the case may be, so as to give such holder the benefit of such more favorable terms or conditions. The conversion price of the June 2021 Convertible Debenture and the exercise price of the Class A and B Warrants are subject to proportional adjustment in the event of stock splits, stock dividends and similar corporate events, including merger or consolidation of the Company or in a “Fundamental Transaction” as defined in the June 2021 Convertible Debenture. The Company has granted the holders certain rights of first refusal on its future offerings for as long as the June 2021 Convertible Debenture or the Class A and B Warrants are outstanding. The Company may prepay and satisfy the June 2021 Convertible Debenture so long as an event of default has not occurred, upon 20 days’ prior written notice received by the Company to the holder, by paying 125% of the amounts owed on the June 2021 Convertible Debenture, including all principal, interest and other fees. The holder of this debenture may, however, convert all or a portion of the debenture during the 20-day notice period. During the six months ended April 30, 2022, the Company issued an aggregate 6,000,000 6,000,000 3,000,000 0.13 3,000,000 0.19 [note 13[b]] 140,942 70,521 effective interest rate of 1,240 [d] April 2022 Convertible Debenture On April 14, 2022, the Company entered into a securities purchase agreement (the “2022 Securities Purchase Agreement”) and closed a non-brokered private placement of an unsecured convertible note in the principal amount of $ 2,000,000 15 October 14, 2023 6,666,667 0.40 The April 2022 Convertible Debenture may not be prepaid prior to maturity and contains customary events of default relating to, among other things, payment defaults, breach of representations and warranties, and breach of provisions of the 2022 Securities Purchase Agreement or the April 2022 Convertible Debenture. In the event of default under the April 2022 Convertible Debenture, the interest rate shall increase to the lesser of 20% per annum or the maximum rate permitted under applicable law until paid and the following “Mandatory Default Amount” shall be paid, if demanded by the purchaser: the sum of (a) the greater of (i) the outstanding principal amount of the April 2022 Convertible Debenture divided by the conversion price on the date the Mandatory Default Amount is either (A) demanded (if demand or notice is required to create an event of default) or otherwise due or (B) paid in full, whichever has a lower conversion price, multiplied by the VWAP on the date the Mandatory Default Amount is either (x) demanded, (y) due, or (z) paid in full, whichever is highest, or (ii) 125% of the outstanding principal amount of the April 2022 Convertible Debenture plus (b) all other amounts, costs, expenses and liquidated damages due in respect of the April 2022 Convertible Debenture. Pursuant to the terms of the 2022 Securities Purchase Agreement, the Company also entered into a registration rights agreement dated April 14, 2022 (the “2022 Registration Rights Agreement”). Pursuant to the terms of the 2022 Registration Rights Agreement, the Company agreed to prepare and file with the SEC a registration statement covering the resale of all shares issued or issuable upon conversion of the April 2022 Convertible Debenture, upon exercise of the respective warrants of the April 2022 Convertible Debenture, upon conversion of the June 2021 Debenture, and upon exercise of the respective warrants of the June 2021 Convertible Debenture. The Company agreed to file the registration statement with the SEC within 30 days following April 14, 2022 and to use best efforts to have the registration statement declared effective by the SEC within 60 days following April 14, 2022 if the SEC does not review it or by August 12, 2022 if the SEC reviews it. In the event the Company fails to file the registration statement or such registration statement is not declared effective within the time periods noted above or such registration statement is not kept effective while any of the securities registered pursuant to such registration statement, the Company will be obligated to pay the holder of the debentures a penalty in cash, in the amount of $ 20,000 As at April 30, 2022, the Company incurred contractual interest of $ 13,151 nil 22% [e] Debt Host Liability and Embedded Derivative Liability Certain of the Company’s convertible debentures were determined to be hybrid financial instruments comprised of a debt host liability and an embedded derivative liability, as under the conversion feature the number of shares that will or may be issued to settle the notes may vary. The Company uses the Black-Scholes Option Pricing Model based on different default risks and assumptions. The debt host liability of the convertible note will be measured at amortized cost, with the embedded derivative liability measured at fair value. On issuance date of the July 2020 Convertible Debenture, the fair value of its debt host liability was determined to be $ 87,083 and the respective embedded derivative liability was valued at $ 25,041 . Fair value adjustments were made to the embedded derivative liability of the July 2020 Convertible Debenture on conversion date of May 18, 2021, resulting in a fair value of $nil. On issuance date of the July 2021 Convertible Debenture, it was determined to be a convertible debt instrument with a beneficial conversion feature accounted for in accordance with ASU 470-20. The Company allocated the intrinsic value of the beneficial conversion feature of the July 2021 Convertible Debenture capped at the face value of $ 79,542 (CA$ 100,000 ) to additional paid-in capital. On November 1, 2021, the Company’s functional currency change resulted in the reclassification of the July 2021 Convertible Debenture to a hybrid financial instrument accounted for in accordance with ASU 815-15. The embedded derivative liability was valued at $ 421,095 (CA$ 529,400 ), the previous beneficial conversion feature was reversed out of additional paid-in capital, and a loss of $ 341,553 (CA$ 429,400 ) was recognized in the statements of loss and comprehensive loss. Fair value adjustments were made to the embedded derivative liability of the July 2021 Convertible Debenture on conversion date of April 22, 2022, resulting in a fair value of $nil. On issuance date of the June 2021 Convertible Debenture, it was determined to be a hybrid financial instrument comprised of a debt host liability and an embedded derivative liability. The embedded derivative liability was valued at $ 1,646,600 1,500,000 1 146,601 7,449,744 600,769 899,231 On issuance date of the April 2022 Convertible Debenture, it was determined to be a convertible debt instrument with a beneficial conversion feature accounted for in accordance with ASU 470-20. The Company allocated the intrinsic value of the beneficial conversion feature of the April 2022 Convertible Debenture of $ 240,000 2 239,998 SCHEDULE OF DERIVATIVE INSTRUMENTS July 2020 Convertible Debenture July 2021 Convertible Debenture June 2021 Convertible Debenture April 2022 Convertible Debenture Total $ $ $ $ $ Debt Host Liability Balance, October 31, 2020 96,318 – – – 96,318 Fair value of debt host liability recognized – – 1 – 1 Accretion and interest expense 23,587 63 43 – 23,693 Conversion (125,560 ) – – – (125,560 ) Foreign currency translation 5,655 – – – 5,655 Balance, October 31, 2021 – 63 44 – 107 Effects of functional currency change – – 1,500,000 – 1,500,000 Fair value at inception – – – 2,000,000 2,000,000 Accretion and interest expense – 28,050 5,610 17,159 50,819 Conversion – (28,031 ) (600,000 ) – (628,031 ) Foreign currency translation – (82 ) – – (82 ) Balance, April 30, 2022 – – 905,654 2,017,159 2,922,813 Embedded Derivative Liability Balance, October 31, 2020 20,123 – – – 20,123 Fair value of embedded derivative liability recognized – – 1,646,600 – 1,646,600 Fair value adjustment (16,058 ) – 5,717,328 – 5,701,270 Conversion (5,247 ) – – – (5,247 ) Foreign currency translation 1,182 – 85,772 – 86,954 Balance, October 31, 2021 – – 7,449,700 – 7,449,700 Effects of functional currency change – 421,094 (7,449,700 ) – (7,028,606 ) Fair value adjustment – (259,447 ) – – (259,447 ) Conversion – (158,169 ) – – (158,169 ) Foreign currency translation – (3,478 ) – – (3,478 ) Balance, April 30, 2022 – – – – – Debt Discount Balance, October 31, 2021 – – – – – Effects of functional currency change – – (1,500,000 ) – (1,500,000 ) Inception – – – (240,000 ) (240,000 ) Amortization – – 600,769 2 600,771 Balance, April 30, 2022 – – (899,231 ) (239,998 ) (1,139,229 ) Combined Value of Convertible Debenture Balance, October 31, 2020 116,441 – – – 116,441 Balance, October 31, 2021 – 63 7,449,744 7,449,744 7,449,807 Balance, April 30, 2022 – – 6,423 1,777,161 1,783,584 The inputs used in the Black-Scholes Option Pricing Model are as follows: SCHEDULE OF OPTION PRICING MODEL April 22, November 1, October 31, June 15, July 27, 2022 2021 2021 2021 2020 Risk free rate of interest 2.65 % 1.07 % 1.08 % 0.31 % 0.26 % Expected life in years 0.23 0.70 1.11 1.50 0.74 Conversion exercise price CA$ 0.12 CA$ 0.12 $ 0.10 $ 0.10 CA$ 0.15 Underlying share price of the Company CA$ 0.36 CA$ 0.75 $ 0.59 $ 0.19 CA$ 0.13 Expected volatility 99.90 % 124.34 % 107.62 % 87.17 % 82.54 % Expected dividend rate Nil Nil Nil Nil Nil [f] Derivative Liability – Warrants and Broker Warrants On November 1, 2021, the Company’s functional currency change resulted in the reclassification of its outstanding warrants and broker warrants denominated in Canadian dollars as derivative liabilities measured at fair value. The previous value of outstanding broker warrants was reversed out of additional paid-in capital, and the derivative liability of warrants and broker warrants were valued at $ 26,956,177 and $ 76,811 , respectively. During the six months ended April 30, 2022, upon exercise of common share purchase warrants, $ 4,482,962 was reclassified from derivative liability to stockholders’ deficit. The Company recognized a loss of $ 7,060,790 in the change in fair value of the derivative liability. As at April 30, 2022, the derivative liability of warrants and broker warrants were valued at $ 2,465,603 and $ 2,658 , respectively. The Company uses the Black-Scholes Option Pricing Model based on default risks and assumptions as appropriate to value its warrants.

SHARE CAPITAL

SHARE CAPITAL	6 Months Ended
	Apr. 30, 2022
Equity [Abstract]
SHARE CAPITAL	13. SHARE CAPITAL [a] Authorized capital The authorized share capital consists of 1,000,000,000 0.001 [b] Common shares issued Fiscal 2021 [i] In connection with the non-brokered private placement announced on September 10, 2020: On November 20, 2020, the Company closed the first tranche of the non-brokered private placement, issuing 5,599,171 0.13 556,876 727,892 On January 15, 2021, the Company closed the second tranche of the non-brokered private placement, consisting of 7,337,914 0.13 749,435 953,930 39,996 On January 29, 2021, the Company closed the third tranche of the non-brokered private placement consisting of 5,382,303 0.13 547,496 699,699 On March 24, 2021, the Company closed the fourth tranche of the non-brokered private placement consisting of 6,554,172 0.13 678,270 852,042 On April 27, 2021, the Company closed the fifth and final tranche of the non-brokered private placement consisting of 851,395 0.13 89,237 110,681 In total, the Company issued an aggregate 25,724,955 0.13 2,621,314 3,344,244 Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche 195,614 [ii] On May 5, 2021, the Company announced a non-brokered private placement priced at CA$ 0.13 3,000,000 5,223,420 0.13 561,844 679,044 17,853,506 0.13 1,880,687 2,320,956 23,076,926 0.13 2,442,531 3,000,000 Each unit issued consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective financing tranche 154,336 [iii] On May 18, 2021, the Company issued a total of 1,360,959 263,973 26,286 [iv] On June 7, 2021, the Company issued 1,538,461 0.24 305,832 369,231 [v] On July 16, 2021, the Company closed a non-brokered private placement and issued 4,350,000 0.20 690,860 870,000 Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing 48,319 [vi] On August 11, 2021, the Company closed a non-brokered private placement and issued 3,827,601 0.55 1,683,336 2,105,180 Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 for a period of eighteen months from the date of closing 124,923 [vii] During the year ended October 31, 2021, the Company issued a total of 7,014,969 0.05 0.21 887,520 1,120,130 525,173 [viii] During the year ended October 31, 2021, the Company issued a total of 2,630,000 0.05 0.16 140,734 175,800 [ix] With respect to the exercises of common share purchase warrants and options, the Company reclassified $ 4,291 121,932 Fiscal 2022 [i] Pursuant to an agreement entered on August 29, 2018 and which was approved by the TSX-V on September 12, 2018, a company controlled by a director and officer was eligible to receive up to 5% of the issued and outstanding common shares of the Company as at August 28, 2018 for up to $ 5 9,163,425 0.65 4,796,832 5,956,226 [ii] On November 4, 2021, the Company issued 1,000,000 1,000,000 500,000 0.13 500,000 0.19 1,000,000 1,000,000 500,000 0.13 500,000 0.19 1,000,000 1,000,000 500,000 0.13 500,000 0.19 1,361 [iii] On November 26, 2021, the Company closed a non-brokered private placement and issued 1,375,499 0.55 756,524 0.75 26,656 [iv] During the three months ended January 31, 2022, upon exercise of common share purchase warrants, the Company issued an aggregate 15,159,448 0.19 2,279,136 2,880,295 200,000 0.05 7,830 10,000 30,000 0.30 6,981 9,000 15,389,448 2,293,946 2,899,295 2,428,363 [v] On March 10, 2022, the Company issued 1,000,000 units on partial conversion of the June 2021 Convertible Debenture, for a total of 1,000,000 common shares, 500,000 Class A Warrants exercisable at a price of $ 0.13 until June 10, 2026, and 500,000 Class B Warrants exercisable at a price of $ 0.19 until June 10, 2026. On April 27, 2022, the Company issued a further 2,000,000 units on partial conversion of the June 2021 Convertible Debenture, for a total of 2,000,000 common shares, 1,000,000 Class A Warrants exercisable at a price of $ 0.13 until June 10, 2026, and 1,000,000 Class B Warrants exercisable at a price of $ 0.19 until June 10, 2026. [vi] On April 22, 2022, the Company issued a total of 933,333 933,333 0.20 100,000 12,000 [vii] During the three months ended April 30, 2022, upon the exercise of common share purchase warrants, the Company issued an aggregate 929,005 0.19 929,005 1,177,755 2,082,025 0.05 81,354 104,101 30,960 0.30 7,357 9,288 3,191,933 40,000 [viii] During the three months ended April 30, 2022, the Company issued a total of 750,000 0.05 29,715 37,500 22,203 [c] Common share purchase warrants A summary of the changes in the Company’s common share purchase warrants during the six months ended April 30, 2022 are as follows: SUMMARY OF CHANGES IN COMMON SHARE PURCHASE WARRANTS Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2021 Granted Exercised Expired/ Cancelled April 30, 2022 Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2021 Granted Exercised Expired/ Cancelled April 30, 2022 November 22, 2021 CA$ 0.19 – 4,160,021 – (4,080,573 ) (79,448 ) – January 17, 2022 CA$ 0.19 – 7,267,914 – (5,959,396 ) (1,308,518 ) – January 31, 2022 CA$ 0.19 – 5,382,303 – (4,341,906 ) (1,040,397 ) – February 21, 2022 CA$ 0.05 – 1,505,200 – (200,000 ) (1,305,200 ) – March 24, 2022 CA$ 0.19 – 6,341,872 – (4,515,139 ) (1,826,733 ) – March 27, 2022 CA$ 0.05 – 982,025 – (882,025 ) (100,000 ) – April 27, 2022 CA$ 0.19 – 791,395 – (791,395 ) – – May 9, 2022 CA$ 0.05 0.02 1,813,725 – (1,000,000 ) – 813,725 May 30, 2022 CA$ 0.19 0.08 5,223,420 – (276,675 ) – 4,946,745 June 17, 2022 CA$ 0.19 0.13 17,703,506 – (1,393,077 ) – 16,310,429 July 18, 2022 CA$ 0.30 0.22 4,350,000 – (60,960 ) – 4,289,040 August 14, 2022 CA$ 0.05 0.29 200,000 – (200,000 ) – – February 13, 2023 CA$ 0.65 0.79 3,827,601 – – – 3,827,601 April 22, 2024 CA$ 0.20 1.98 – 933,333 – – 933,333 Subtotal 59,548,982 933,333 (23,701,146 ) (5,660,296 ) 31,120,873 Weighted average exercise price CA$ 0.22 CA$ 0.20 CA$ 0.18 CA$ 0.16 CA$ 0.26 November 27, 2022 US$ 0.75 0.58 – 1,375,499 – – 1,375,499 June 10, 2026 US$ 0.13 4.12 – 3,000,000 – – 1,500,000 June 10, 2026 US$ 0.19 4.12 – 3,000,000 – – 1,500,000 Subtotal – 7,375,499 – – 4,375,499 Weighted average exercise price – US$ 0.27 – – US$ 0.27 Total 59,548,982 8,308,832 (23,701,146 ) (5,660,296 ) 38,496,372 A summary of the changes in the Company’s common share purchase warrants during the six months ended April 30, 2021 are as follows: Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2020 Granted Exercised Expired/ Cancelled April 30, 2021 August 31, 2021 * CA$ 0.21 0.34 3,643,791 – – – 3,643,791 November 22, 2021 CA$ 0.19 0.56 – 5,599,171 – – 5,599,171 January 17, 2022 CA$ 0.19 0.71 – 7,337,914 – – 7,337,914 January 31, 2022 CA$ 0.19 0.75 – 5,382,303 – – 5,382,303 February 21, 2022 CA$ 0.05 0.81 1,505,200 – – – 1,505,200 March 24, 2022 CA$ 0.19 0.90 – 6,554,172 – – 6,554,172 March 27, 2022 CA$ 0.05 0.91 1,482,025 – – – 1,482,025 April 27, 2022 CA$ 0.19 0.99 – 851,395 – – 851,395 May 9, 2022 CA$ 0.05 1.02 2,368,626 – – – 2,368,626 August 14, 2022 CA$ 0.05 1.29 1,110,000 – (400,000 ) – 710,000 Total 10,109,642 25,724,955 (400,000 ) – 35,434,597 Weighted average exercise price CA$ 0.11 CA$ 0.19 CA$ 0.05 – CA$ 0.17 * The Company received approval of the TSX-V on January 13, 2021 and amended the expiry date of 3,643,791 extending the expiry date from January 17, 2021 to August 31, 2021 0.30 [d] Stock options The Company has adopted an incentive stock option plan, effective on August 8, 2017 and as amended on August 8, 2018, under the rules of the TSX-V pursuant to which it is authorized to grant stock options to executive officers, directors, employees and consultants, enabling them to acquire up to 20 Stock options granted are subject to a maximum term of 5 years. All options granted shall vest immediately, except for those options granted to persons performing investor relations activities for the Company On June 11, 2021, the Company adopted the 2021 Equity Incentive Plan which replaces the 2017 Stock Option for providing stock-based compensation to directors, officers, employees, consultants, and advisors of the Company and no further options will be granted under the 2017 Stock Option Plan. Under the 2021 Equity Incentive Plan, the Company is authorized to issue up 27,312,368 5,980,000 1,730,000 33,292,368 2,9,042,368 On December 30, 2020, the Company granted 15,650,000 0.13 9,500,000 6,150,000 On August 30, 2021, the Company granted 21,700,000 0.70 five years On October 1, 2021, the Company granted 1,450,000 0.50 five years On December 3, 2021, the Company granted 250,000 0.58 five years On March 7, 2022, the Company granted 500,000 0.40 five years On April 8, 2022, the Company granted 500,000 0.40 five years As at April 30, 2022, 9,092,368 During the six months April 30, 2022, the Company recognized a stock-based compensation totaling $ 433,829 nil The weighted average grant date fair value of the stock options granted during the six months ended April 30, 2022 was CA$ 0.37 0.09 SCHEDULE OF FAIR VALUE ASSUMPTIONS 2022 2021 Risk free rate of interest 1.34 2.59 0.20 1.07 Expected life of options 5 2 5 Exercise price of options CA$ 0.40 0.58 CA$ 0.13 0.70 Expected annualized volatility 134.93 136.08 130.88 140.05 Expected dividend rate Nil Nil A summary of the changes in the Company’s stock options during the six months ended April 30, 2022 are as follows: SCHEDULE OF STOCK OPTIONS ACTIVITY Expiry Date Exercise Price Weighted Average Life (Years) Outstanding as at October 31, 2021 Granted Exercised Expired/ Cancelled Outstanding as at April 30, 2022 Vested as at April 30, 2022 March 27, 2022 0.05 – 1,500,000 – (750,000 ) (750,000 ) – – December 30, 2022 0.13 0.67 6,000,000 – – (150,000 ) 5,850,000 5,850,000 August 12, 2023 0.05 1.28 2,290,000 – – (750,000 ) 1,540,000 1,540,000 December 3, 2023 0.05 1.59 6,450,000 – – (1,000,000 ) 5,450,000 5,450,000 May 22, 2024 0.12 2.06 7,900,000 – – (850,000 ) 7,050,000 7,050,000 November 3, 2024 0.15 2.52 700,000 – – – 700,000 700,000 November 24, 2024 0.16 2.57 320,000 – – (300,000 ) 20,000 20,000 March 26, 2025 0.11 2.91 100,000 – – – 100,000 100,000 April 23, 2025 0.12 2.98 3,350,000 – – (250,000 ) 3,100,000 3,100,000 December 30, 2025 0.13 3.67 9,500,000 – – – 9,500,000 9,500,000 August 30, 2026 0.70 4.34 21,700,000 – – (200,000 ) 21,500,000 21,350,000 October 1, 2026 0.50 4.42 1,450,000 – – – 1,450,000 1,450,000 December 3, 2026 0.58 4.60 – 250,000 – – 250,000 250,000 March 7, 2027 0.40 4.85 – 500,000 – – 500,000 500,000 April 8, 2027 0.40 4.94 – 500,000 – – 500,000 500,000 Total 61,260,000 1,250,000 (750,000 ) (4,250,000 ) 57,510,000 57,360,000 Weighted average exercise price CA$ 0.33 CA$ 0.44 CA$ 0.05 CA$ 0.11 CA$ 0.34 CA$ 0.33 Aggregate intrinsic value $ 19,994,025 $ (2,149,050 ) $ (2,102,148 ) Weighted average remaining life 3.46 3.15 3.15 A summary of the changes in the Company’s nonvested stock options during the six months ended April 30, 2022 are as follows: SCHEDULE OF NONVESTED STOCK OPTIONS Expiry Date Fair Value Per Share Weighted Average Life (Years) Nonvested as at October 31, 2021 Granted Vested Expired/ Cancelled Nonvested as at April 30, 2022 December 30, 2022 0.07 1.16 162,500 – (162,500 ) – – August 30, 2026 0.56 4.83 300,000 – (150,000 ) – 150,000 Total 462,500 – (312,500 ) – 150,000 Weighted average grant date fair value – per option CA$ 0.39 – CA$ 0.30 – CA$ 0.56 Weighted average grant date fair value – total $ 144,131 – $ 74,063 – $ 65,463 A summary of the changes in the Company’s stock options during the six months ended April 30, 2021 are as follows: Expiry Date Exercise Price Weighted Average Life (Years) Outstanding as at October 31, 2020 Granted Exercised Expired/ Cancelled Outstanding as at April 30, 2021 Vested as at April 30, 2021 February 11, 2021 0.05 0.03 800,000 – – (800,000 ) – – August 16, 2021 0.05 0.54 600,000 – – – 600,000 600,000 March 27, 2022 0.05 1.15 1,750,000 – – – 1,750,000 1,750,000 August 26, 2022 0.13 – 500,000 – – (500,000 ) – – December 30, 2022 0.13 1.91 – 6,150,000 – (6,150,000 ) – – April 19, 2023 0.05 2.21 800,000 – – – 800,000 800,000 August 12, 2023 0.05 2.53 3,120,000 – (100,000 ) – 3,020,000 3,020,000 December 3, 2023 0.05 2.84 7,000,000 – – – 7,000,000 7,000,000 May 22, 2024 0.12 3.31 7,950,000 – – – 7,950,000 7,950,000 November 3, 2024 0.15 3.76 700,000 – – – 700,000 700,000 November 24, 2024 0.16 3.82 900,000 – – – 900,000 900,000 March 26, 2025 0.11 4.15 300,000 – – – 300,000 300,000 April 23, 2025 0.12 4.23 4,000,000 – – (300,000 ) 3,700,000 3,700,000 December 30, 2025 0.13 4.92 – 9,500,000 – (9,500,000 ) – – Total 28,420,000 15,650,000 (100,000 ) (17,250,000 ) 26,720,000 26,720,000 Weighted average exercise price CA$ 0.09 CA$ 0.13 CA$ 0.05 CA$ 0.13 CA$ 0.09 CA$ 0.09 Aggregate intrinsic value $ 801,922 $ 597,721 $ 597,721 Weighted average remaining life 3.18 2.78 2.78 [e] Share-based payments and other reserves The share-based payments and other reserves are used to recognize the fair value of stock options granted to directors, officers, employees and consultants as part of their remuneration, as well as those of broker warrants issued in relation to the Company’s financings. When stock options and broker warrants are subsequently exercised, the fair value of such stock options and broker warrants in additional paid-in capital is credited to share capital. Common share purchase warrants attached to units as part of a unit placement were assigned a $ nil On November 1, 2021, the Company’s functional currency change resulted in the reclassification of its outstanding warrants and broker warrants denominated in Canadian dollars as a derivative liability. The fair value of outstanding broker warrants was reversed out of additional paid-in capital. On November 1, 2021, the Company’s functional currency change resulted in the reclassification of the June 2021 Convertible Debenture from a hybrid financial instrument to a convertible debt instrument with a beneficial conversion feature. The value of the embedded derivative liability was reclassified to additional paid-in capital. [f] Obligations to issue shares As at April 30, 2022, the Company received advance share subscriptions in the amount of $ 388,701 209,827 [g] Dilutive common shares As at April 30, 2022, potentially dilutive common shares relating to common share purchase warrants and options outstanding totaling 96,006,372 120,808,982

FINANCIAL INSTRUMENTS AND FINAN

FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT	6 Months Ended
	Apr. 30, 2022
Fair Value Disclosures [Abstract]
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT	14. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT The Company’s classification of its financial instruments is as follows: SCHEDULE OF CLASSIFICATION OF FINANCIAL INSTRUMENTS Financial Instruments Measurement Method Associated Risk Fair Value at April 30, 2022 ($) Cash FVTPL Credit and currency 774,409 Other receivables Amortized cost Credit and currency 50,765 Subscription receivable Amortized cost Credit and currency 185,000 Deposits held by related parties Amortized cost Credit and currency 388,757 Accounts payable and accrued liabilities Amortized cost Currency 2,715,924 Due to related parties Amortized cost Currency 1,253,280 Convertible debenture, net Amortized cost Currency 1,783,584 Warrant liability FVTPL Currency 2,468,261 [a] Fair value The fair value of financial instruments is the amount of consideration that would be agreed upon in an arm’s length transaction between knowledgeable, willing parties who are under no compulsion to act. The fair value of current financial instruments except derivative liability approximates their carrying values as long as they are short-term in nature or bear interest at market rates. [b] Fair value hierarchy Financial instruments that are held at fair value are categorized based on a valuation hierarchy which is determined by the valuation methodology utilized. The fair value hierarchy under US GAAP is based on the following three levels of inputs, of which the first two are considered observable and the last unobservable: Level 1 Level 2 Level 3 The Company evaluates its financial instruments and other contracts to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market at each balance sheet date and recorded as a liability and the change in fair value is recorded in the consolidated statements of loss and comprehensive loss. Upon conversion or exercise of a derivative instrument, the instrument is marked to market at the conversion date and then that fair value is reclassified to equity. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Derivative instruments that become subject to reclassification are reclassified at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified on the consolidated balance sheets as current or non-current based on whether or not settlement of the derivative instrument is expected within 12 months of the balance sheet date. The Company uses the Black-Scholes Option Pricing Model to value derivative liabilities. This model uses Level 3 inputs in the fair value hierarchy established by ASC 820 Fair Value Measurement. The inputs used in determining the fair value of the embedded derivative are disclosed in note 12[e] [c] Financial risk management The Company’s board of directors has the overall responsibility for the establishment and oversight of the Company’s risk management framework. The Company’s risk management policies are established to identify and analyze the risks faced by the Company, to set appropriate risk limits and controls, and to monitor risks and adherence to limits. Risk management policies and systems are reviewed regularly to reflect changes in market conditions and in response to the Company’s activities. Management regularly monitors compliance with the Company’s risk management policies and procedures and reviews the adequacy of the risk management framework in relation to the risks faced by the Company. In the normal course of operations, the Company is exposed to various risks such interest rate, foreign exchange, commodity, credit, and liquidity. To manage these risks, management determines what activities must be undertaken to minimize potential exposure to risks. The objectives of the Company in managing risks are as follows: ● Maintaining sound financial condition: ● Financing operations; and ● Ensuring liquidity to all operations. In order to satisfy these objectives, the Company has adopted the following policies: ● Prepare budget documents at prevailing market rates to ensure clear corporate alignment to performance management and achievement of targets; ● Recognize and observe the extent of operating risk within the business; and ● Identify the magnitude of the impact of market risk factors on the overall risk of the business and take advantage of natural risk reductions that arise from these relationships. [i] Interest rate risk Interest rate risk is the risk that future cash flows of a financial instrument will fluctuate because of changes in the market interest rates. The Company is exposed to interest rate risk on its cash on deposits with banks and, from time to time, on its holdings of short-term investments. As of April 30, 2022, the Company had $ 774,409 462,360 no [ii] Foreign currency risk The Company is exposed to foreign currency risk on fluctuations related to cash, other receivables, accounts payable, due to related parties and convertible debenture that are denominated in Canadian dollars. The Company has not entered into foreign exchange derivative contracts. A significant change in the currency exchange rates between the US dollar relative to the Canadian dollar could have a material effect on the Company’s financial position, results of operations, or cash flows. Based on the Company net exposures as at April 30, 2022, assuming that all other variables remain constant, a 5 78,312 The Company had the following assets and liabilities denominated in Canadian dollars: SCHEDULE OF FOREIGN CURRENCY RISK April 30, 2022 CA$ Cash 208,683 Other receivables 64,930 Accounts payable and accrued liabilities (1,511,845 ) Due to related parties (765,409 ) Total (2,003,641 ) [iii] Commodity price risk The value of the Company’s magnesium production business and its exploration and evaluation assets are dependent on the price of magnesium and the outlook for this mineral. Market prices for these metals historically have fluctuated widely and are affected by numerous factors outside the Company’s control, including but not limited to, levels of worldwide production, short-term changes in supply and demand, industrial and retail demand, as well as certain other factors related specifically to magnesium. If magnesium prices decline for a prolonged period below the cost of production, it may not be economically feasible to continue towards production. [iv] Credit risk Credit risk is the risk of loss if counterparties do not fulfill their contractual obligations and arises principally from trade receivables. The Company’s credit risk is primarily attributable to cash, and deposits held by related parties. The Company limits its exposure to credit risk on cash as these financial instruments are held with major Canadian and international banks. Other receivables consist primarily of GST due from the Federal Government of Canada. Management believes the credit risk concentration with respect to other receivables is remote. The carrying amount of financial assets recorded in the financial statements, net of any allowances, represents the Company’s maximum exposure to credit risk. [v] Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they come due. The Company’s exposure to liquidity risk is dependent on its purchasing commitments and obligations and its ability to raise funds to meet commitments and sustain operations. The Company manages liquidity risk by continuously monitoring its actual and forecasted working capital requirements to ensure there is capital to meet short-term and long-term obligations. As of April 30, 2022 and October 31, 2021, the Company had working capital deficiency of $ 7,172,573 and $ 9,657,316 , respectively. As disclosed in note 1

SEGMENTED INFORMATION

SEGMENTED INFORMATION	6 Months Ended
	Apr. 30, 2022
Segment Reporting [Abstract]
SEGMENTED INFORMATION	15. SEGMENTED INFORMATION The Company focuses on plant operations and magnesium production and continues to move towards the buildout of its pilot plant facility and the development of a full-scale commercial magnesium production facility. The Company also owns mining claims for the exploration and development of mineral property interests. Geographic information for the Company’s assets is as follows: SCHEDULE OF ASSETS INFORMATION April 30, 2022 October 31, 2021 $ $ Canada – property, plant and equipment 3,946,315 2,546,383 United States – property, plant and equipment 31,304 28,321 United States – mineral property costs 93,453 93,453 Property, plant and equipment net 4,071,072 2,668,157 Canada – other assets 392,853 1,554,827 United States – other assets 1,611,578 290,528 Other assets 2,004,431 1,845,355 Total Assets 6,075,503 4,513,512

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Apr. 30, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	16. SUBSEQUENT EVENTS Subsequent to April 30 2022, upon exercise of common share purchase warrants, the Company issued an aggregate 3,793,331 0.19 720,733 800,000 0.05 40,000 1,153,414 13,725 Subsequent to April 30, 2022, upon exercise of stock options, the Company issued 300,000 0.05 15,000 250,000 0.13 32,500 On May 9, 2022, the Company closed the first tranche of a non-brokered private placement and issued 1,727,000 units at a price of $ 0.25 per unit for gross proceeds of $ 431,750 . On June 3, 2022, the Company closed the second and final tranche of the non-brokered private placement and issued 740,000 0.25 185,000 2,467,000 616,750 Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of $0.45 for a period of one year from the date of closing . On June 8, 2022, the Company issued 1,000,000 1,000,000 500,000 0.13 500,000 0.19

PROPERTY, PLANT AND EQUIPMENT (

PROPERTY, PLANT AND EQUIPMENT (Tables)	6 Months Ended
	Apr. 30, 2022
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT	SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT Computer Equipment Furniture Leasehold Improvement Furnace & Plant Equipment Vehicle Total $ $ $ $ $ $ Cost Balance, October 31, 2020 32,318 38,916 7,610 28,413 – 107,257 Additions 77,955 11,510 129,257 2,278,205 – 2,496,927 Write-off of equipment (4,245 ) – – – – (4,245 ) Foreign exchange effect 3,601 3,116 2,614 38,108 – 47,439 Balance, October 31, 2021 109,629 53,542 139,481 2,344,726 – 2,647,378 Additions 7,008 2,171 107,014 1,456,591 29,215 1,601,999 Foreign exchange effect – (288 ) (5,306 ) (70,509 ) (302 ) (76,405 ) Balance, April 30, 2022 116,637 55,425 241,189 3,730,808 28,913 4,172,972 Accumulated Depreciation Balance, October 31, 2020 14,677 8,326 4,818 – – 27,821 Depreciation expense 13,907 7,443 8,827 13,971 – 44,148 Write-off of equipment (2,057 ) – – – – (2,057 ) Foreign exchange effect 1,294 745 502 221 – 2,762 Balance, October 31, 2021 27,821 16,514 14,147 14,192 – 72,674 Depreciation expense 18,236 3,833 15,217 83,755 2,920 123,961 Foreign exchange effect – (48 ) (404 ) (801 ) (29 ) (1,282 ) Balance, April 30, 2022 46,057 20,299 28,960 97,146 2,891 195,353 Net Book Value Balance, October 31, 2020 17,641 30,590 2,792 28,413 – 79,436 Balance, October 31, 2021 81,808 37,028 125,334 2,330,534 – 2,574,704 Balance, April 30, 2022 70,580 35,126 212,229 3,633,662 26,022 3,977,619

RIGHT-OF-USE ASSETS (Tables)

RIGHT-OF-USE ASSETS (Tables)	6 Months Ended
	Apr. 30, 2022
Right-of-use Assets
SCHEDULE OF RIGHT- OF - USE ASSETS	SCHEDULE OF RIGHT- OF - USE ASSETS Vancouver Office Virginia Office Nevada Office Pilot Plant Total $ $ $ $ $ Cost Balance, October 31, 2020 59,701 – 22,856 357,949 440,506 Additions 91,237 287,847 – – 379,084 Foreign exchange effect 5,943 4,544 1,724 26,997 39,208 Balance, October 31, 2021 156,881 292,391 24,580 384,946 858,798 Foreign exchange effect – (3,038 ) – (12,278 ) (15,316 ) Balance, April 30, 2022 156,881 289,353 24,580 372,668 843,482 Accumulated Depreciation Balance, October 31, 2020 42,142 – 14,434 9,943 66,519 Depreciation expense 44,259 15,288 8,915 117,292 185,754 Foreign exchange effect 3,876 241 1,231 2,602 7,950 Balance, October 31, 2021 90,277 15,529 24,580 129,837 260,223 Depreciation expense 22,229 33,790 – 62,347 118,366 Foreign exchange effect – (162 ) – (4,766 ) (4,928 ) Balance, April 30, 2022 112,506 49,157 24,580 187,418 373,661 Net Book Value Balance, October 31, 2020 17,559 – 8,422 348,006 373,987 Balance, October 31, 2021 66,604 276,862 – 255,109 598,575 Balance, April 30, 2022 44,375 240,196 – 185,250 469,821

LEASE OBLIGATIONS (Tables)

LEASE OBLIGATIONS (Tables)	6 Months Ended
	Apr. 30, 2022
Lease Obligations
SCHEDULE OF OPERATING LEASE	SCHEDULE OF OPERATING LEASE Vancouver Office Virginia Office Nevada Office Pilot Plant Total $ $ $ $ $ Balance, October 31, 2020 18,123 – 12,211 350,593 380,927 Additions 91,237 260,649 – – 351,886 Lease payments (47,931 ) (5,137 ) (9,457 ) (139,037 ) (201,562 ) Interest expense 3,076 3,019 219 19,005 25,319 Prior period adjustment – – (3,065 ) – (3,065 ) Foreign exchange effect 2,099 4,081 92 24,548 30,820 Balance, October 31, 2021 66,604 262,612 – 255,109 584,325 Lease payments (24,187 ) – – (69,057 ) (93,244 ) Interest expense 1,958 9,230 – 6,711 17,899 Foreign exchange effect – (2,728 ) – (7,513 ) (10,241 ) Balance, April 30, 2022 44,375 269,114 – 185,250 498,739 Which consist of: Current lease obligation 44,375 71,092 – 129,125 244,592 Non-current lease obligation – 198,022 – 56,125 254,147 Balance, April 30, 2022 44,375 269,114 – 185,250 498,739

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	6 Months Ended
	Apr. 30, 2022
Related Party Transactions [Abstract]
SCHEDULE OF DEPOSITS HELD BY RELATED PARTY	SCHEDULE OF DEPOSITS HELD BY RELATED PARTY Related Party A [i] Related Party B [ii] Total $ $ $ Balance, October 31, 2020 – – – Advances 987,912 2,292,912 3,280,824 Costs and expenses (696,431 ) (2,097,931 ) (2,794,362 ) Balance, October 31, 2021 291,481 194,981 486,462 Advances 330,930 1,225,118 1,556,048 Costs and expenses (249,872 ) (1,420,829 ) (1,670,701 ) Foreign exchange effect 16,218 730 16,948 Balance, April 30, 2022 388,757 – 388,757 [i] Related Party A is a company controlled by a director and officer. [ii] Related Party B is a company controlled by an officer.
SCHEDULE OF DUE TO RELATED PARTIES	SCHEDULE OF DUE TO RELATED PARTIES April 30, 2022 October 31, $ $ Wages payable to directors and officers 357,500 357,500 Benefits payable to directors and officers 730,810 539,209 Fees and expenses payable to directors and officers 164,970 127,878 Interest due to a shareholder – 2,230 Total 1,253,280 1,026,817

CONVERTIBLE DEBENTURE AND DER_2

CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY (Tables)	6 Months Ended
	Apr. 30, 2022
Debt Disclosure [Abstract]
SCHEDULE OF DERIVATIVE INSTRUMENTS	SCHEDULE OF DERIVATIVE INSTRUMENTS July 2020 Convertible Debenture July 2021 Convertible Debenture June 2021 Convertible Debenture April 2022 Convertible Debenture Total $ $ $ $ $ Debt Host Liability Balance, October 31, 2020 96,318 – – – 96,318 Fair value of debt host liability recognized – – 1 – 1 Accretion and interest expense 23,587 63 43 – 23,693 Conversion (125,560 ) – – – (125,560 ) Foreign currency translation 5,655 – – – 5,655 Balance, October 31, 2021 – 63 44 – 107 Effects of functional currency change – – 1,500,000 – 1,500,000 Fair value at inception – – – 2,000,000 2,000,000 Accretion and interest expense – 28,050 5,610 17,159 50,819 Conversion – (28,031 ) (600,000 ) – (628,031 ) Foreign currency translation – (82 ) – – (82 ) Balance, April 30, 2022 – – 905,654 2,017,159 2,922,813 Embedded Derivative Liability Balance, October 31, 2020 20,123 – – – 20,123 Fair value of embedded derivative liability recognized – – 1,646,600 – 1,646,600 Fair value adjustment (16,058 ) – 5,717,328 – 5,701,270 Conversion (5,247 ) – – – (5,247 ) Foreign currency translation 1,182 – 85,772 – 86,954 Balance, October 31, 2021 – – 7,449,700 – 7,449,700 Effects of functional currency change – 421,094 (7,449,700 ) – (7,028,606 ) Fair value adjustment – (259,447 ) – – (259,447 ) Conversion – (158,169 ) – – (158,169 ) Foreign currency translation – (3,478 ) – – (3,478 ) Balance, April 30, 2022 – – – – – Debt Discount Balance, October 31, 2021 – – – – – Effects of functional currency change – – (1,500,000 ) – (1,500,000 ) Inception – – – (240,000 ) (240,000 ) Amortization – – 600,769 2 600,771 Balance, April 30, 2022 – – (899,231 ) (239,998 ) (1,139,229 ) Combined Value of Convertible Debenture Balance, October 31, 2020 116,441 – – – 116,441 Balance, October 31, 2021 – 63 7,449,744 7,449,744 7,449,807 Balance, April 30, 2022 – – 6,423 1,777,161 1,783,584
SCHEDULE OF OPTION PRICING MODEL	The inputs used in the Black-Scholes Option Pricing Model are as follows: SCHEDULE OF OPTION PRICING MODEL April 22, November 1, October 31, June 15, July 27, 2022 2021 2021 2021 2020 Risk free rate of interest 2.65 % 1.07 % 1.08 % 0.31 % 0.26 % Expected life in years 0.23 0.70 1.11 1.50 0.74 Conversion exercise price CA$ 0.12 CA$ 0.12 $ 0.10 $ 0.10 CA$ 0.15 Underlying share price of the Company CA$ 0.36 CA$ 0.75 $ 0.59 $ 0.19 CA$ 0.13 Expected volatility 99.90 % 124.34 % 107.62 % 87.17 % 82.54 % Expected dividend rate Nil Nil Nil Nil Nil

SHARE CAPITAL (Tables)

SHARE CAPITAL (Tables)	6 Months Ended
	Apr. 30, 2022
Equity [Abstract]
SUMMARY OF CHANGES IN COMMON SHARE PURCHASE WARRANTS	A summary of the changes in the Company’s common share purchase warrants during the six months ended April 30, 2022 are as follows: SUMMARY OF CHANGES IN COMMON SHARE PURCHASE WARRANTS Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2021 Granted Exercised Expired/ Cancelled April 30, 2022 Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2021 Granted Exercised Expired/ Cancelled April 30, 2022 November 22, 2021 CA$ 0.19 – 4,160,021 – (4,080,573 ) (79,448 ) – January 17, 2022 CA$ 0.19 – 7,267,914 – (5,959,396 ) (1,308,518 ) – January 31, 2022 CA$ 0.19 – 5,382,303 – (4,341,906 ) (1,040,397 ) – February 21, 2022 CA$ 0.05 – 1,505,200 – (200,000 ) (1,305,200 ) – March 24, 2022 CA$ 0.19 – 6,341,872 – (4,515,139 ) (1,826,733 ) – March 27, 2022 CA$ 0.05 – 982,025 – (882,025 ) (100,000 ) – April 27, 2022 CA$ 0.19 – 791,395 – (791,395 ) – – May 9, 2022 CA$ 0.05 0.02 1,813,725 – (1,000,000 ) – 813,725 May 30, 2022 CA$ 0.19 0.08 5,223,420 – (276,675 ) – 4,946,745 June 17, 2022 CA$ 0.19 0.13 17,703,506 – (1,393,077 ) – 16,310,429 July 18, 2022 CA$ 0.30 0.22 4,350,000 – (60,960 ) – 4,289,040 August 14, 2022 CA$ 0.05 0.29 200,000 – (200,000 ) – – February 13, 2023 CA$ 0.65 0.79 3,827,601 – – – 3,827,601 April 22, 2024 CA$ 0.20 1.98 – 933,333 – – 933,333 Subtotal 59,548,982 933,333 (23,701,146 ) (5,660,296 ) 31,120,873 Weighted average exercise price CA$ 0.22 CA$ 0.20 CA$ 0.18 CA$ 0.16 CA$ 0.26 November 27, 2022 US$ 0.75 0.58 – 1,375,499 – – 1,375,499 June 10, 2026 US$ 0.13 4.12 – 3,000,000 – – 1,500,000 June 10, 2026 US$ 0.19 4.12 – 3,000,000 – – 1,500,000 Subtotal – 7,375,499 – – 4,375,499 Weighted average exercise price – US$ 0.27 – – US$ 0.27 Total 59,548,982 8,308,832 (23,701,146 ) (5,660,296 ) 38,496,372 A summary of the changes in the Company’s common share purchase warrants during the six months ended April 30, 2021 are as follows: Expiry Date Exercise Price Weighted Average Life (Years) October 31, 2020 Granted Exercised Expired/ Cancelled April 30, 2021 August 31, 2021 * CA$ 0.21 0.34 3,643,791 – – – 3,643,791 November 22, 2021 CA$ 0.19 0.56 – 5,599,171 – – 5,599,171 January 17, 2022 CA$ 0.19 0.71 – 7,337,914 – – 7,337,914 January 31, 2022 CA$ 0.19 0.75 – 5,382,303 – – 5,382,303 February 21, 2022 CA$ 0.05 0.81 1,505,200 – – – 1,505,200 March 24, 2022 CA$ 0.19 0.90 – 6,554,172 – – 6,554,172 March 27, 2022 CA$ 0.05 0.91 1,482,025 – – – 1,482,025 April 27, 2022 CA$ 0.19 0.99 – 851,395 – – 851,395 May 9, 2022 CA$ 0.05 1.02 2,368,626 – – – 2,368,626 August 14, 2022 CA$ 0.05 1.29 1,110,000 – (400,000 ) – 710,000 Total 10,109,642 25,724,955 (400,000 ) – 35,434,597 Weighted average exercise price CA$ 0.11 CA$ 0.19 CA$ 0.05 – CA$ 0.17 * The Company received approval of the TSX-V on January 13, 2021 and amended the expiry date of 3,643,791 extending the expiry date from January 17, 2021 to August 31, 2021 0.30
SCHEDULE OF FAIR VALUE ASSUMPTIONS	SCHEDULE OF FAIR VALUE ASSUMPTIONS 2022 2021 Risk free rate of interest 1.34 2.59 0.20 1.07 Expected life of options 5 2 5 Exercise price of options CA$ 0.40 0.58 CA$ 0.13 0.70 Expected annualized volatility 134.93 136.08 130.88 140.05 Expected dividend rate Nil Nil
SCHEDULE OF STOCK OPTIONS ACTIVITY	A summary of the changes in the Company’s stock options during the six months ended April 30, 2022 are as follows: SCHEDULE OF STOCK OPTIONS ACTIVITY Expiry Date Exercise Price Weighted Average Life (Years) Outstanding as at October 31, 2021 Granted Exercised Expired/ Cancelled Outstanding as at April 30, 2022 Vested as at April 30, 2022 March 27, 2022 0.05 – 1,500,000 – (750,000 ) (750,000 ) – – December 30, 2022 0.13 0.67 6,000,000 – – (150,000 ) 5,850,000 5,850,000 August 12, 2023 0.05 1.28 2,290,000 – – (750,000 ) 1,540,000 1,540,000 December 3, 2023 0.05 1.59 6,450,000 – – (1,000,000 ) 5,450,000 5,450,000 May 22, 2024 0.12 2.06 7,900,000 – – (850,000 ) 7,050,000 7,050,000 November 3, 2024 0.15 2.52 700,000 – – – 700,000 700,000 November 24, 2024 0.16 2.57 320,000 – – (300,000 ) 20,000 20,000 March 26, 2025 0.11 2.91 100,000 – – – 100,000 100,000 April 23, 2025 0.12 2.98 3,350,000 – – (250,000 ) 3,100,000 3,100,000 December 30, 2025 0.13 3.67 9,500,000 – – – 9,500,000 9,500,000 August 30, 2026 0.70 4.34 21,700,000 – – (200,000 ) 21,500,000 21,350,000 October 1, 2026 0.50 4.42 1,450,000 – – – 1,450,000 1,450,000 December 3, 2026 0.58 4.60 – 250,000 – – 250,000 250,000 March 7, 2027 0.40 4.85 – 500,000 – – 500,000 500,000 April 8, 2027 0.40 4.94 – 500,000 – – 500,000 500,000 Total 61,260,000 1,250,000 (750,000 ) (4,250,000 ) 57,510,000 57,360,000 Weighted average exercise price CA$ 0.33 CA$ 0.44 CA$ 0.05 CA$ 0.11 CA$ 0.34 CA$ 0.33 Aggregate intrinsic value $ 19,994,025 $ (2,149,050 ) $ (2,102,148 ) Weighted average remaining life 3.46 3.15 3.15 A summary of the changes in the Company’s stock options during the six months ended April 30, 2021 are as follows: Expiry Date Exercise Price Weighted Average Life (Years) Outstanding as at October 31, 2020 Granted Exercised Expired/ Cancelled Outstanding as at April 30, 2021 Vested as at April 30, 2021 February 11, 2021 0.05 0.03 800,000 – – (800,000 ) – – August 16, 2021 0.05 0.54 600,000 – – – 600,000 600,000 March 27, 2022 0.05 1.15 1,750,000 – – – 1,750,000 1,750,000 August 26, 2022 0.13 – 500,000 – – (500,000 ) – – December 30, 2022 0.13 1.91 – 6,150,000 – (6,150,000 ) – – April 19, 2023 0.05 2.21 800,000 – – – 800,000 800,000 August 12, 2023 0.05 2.53 3,120,000 – (100,000 ) – 3,020,000 3,020,000 December 3, 2023 0.05 2.84 7,000,000 – – – 7,000,000 7,000,000 May 22, 2024 0.12 3.31 7,950,000 – – – 7,950,000 7,950,000 November 3, 2024 0.15 3.76 700,000 – – – 700,000 700,000 November 24, 2024 0.16 3.82 900,000 – – – 900,000 900,000 March 26, 2025 0.11 4.15 300,000 – – – 300,000 300,000 April 23, 2025 0.12 4.23 4,000,000 – – (300,000 ) 3,700,000 3,700,000 December 30, 2025 0.13 4.92 – 9,500,000 – (9,500,000 ) – – Total 28,420,000 15,650,000 (100,000 ) (17,250,000 ) 26,720,000 26,720,000 Weighted average exercise price CA$ 0.09 CA$ 0.13 CA$ 0.05 CA$ 0.13 CA$ 0.09 CA$ 0.09 Aggregate intrinsic value $ 801,922 $ 597,721 $ 597,721 Weighted average remaining life 3.18 2.78 2.78
SCHEDULE OF NONVESTED STOCK OPTIONS	A summary of the changes in the Company’s nonvested stock options during the six months ended April 30, 2022 are as follows: SCHEDULE OF NONVESTED STOCK OPTIONS Expiry Date Fair Value Per Share Weighted Average Life (Years) Nonvested as at October 31, 2021 Granted Vested Expired/ Cancelled Nonvested as at April 30, 2022 December 30, 2022 0.07 1.16 162,500 – (162,500 ) – – August 30, 2026 0.56 4.83 300,000 – (150,000 ) – 150,000 Total 462,500 – (312,500 ) – 150,000 Weighted average grant date fair value – per option CA$ 0.39 – CA$ 0.30 – CA$ 0.56 Weighted average grant date fair value – total $ 144,131 – $ 74,063 – $ 65,463

FINANCIAL INSTRUMENTS AND FIN_2

FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables)	6 Months Ended
	Apr. 30, 2022
Fair Value Disclosures [Abstract]
SCHEDULE OF CLASSIFICATION OF FINANCIAL INSTRUMENTS	The Company’s classification of its financial instruments is as follows: SCHEDULE OF CLASSIFICATION OF FINANCIAL INSTRUMENTS Financial Instruments Measurement Method Associated Risk Fair Value at April 30, 2022 ($) Cash FVTPL Credit and currency 774,409 Other receivables Amortized cost Credit and currency 50,765 Subscription receivable Amortized cost Credit and currency 185,000 Deposits held by related parties Amortized cost Credit and currency 388,757 Accounts payable and accrued liabilities Amortized cost Currency 2,715,924 Due to related parties Amortized cost Currency 1,253,280 Convertible debenture, net Amortized cost Currency 1,783,584 Warrant liability FVTPL Currency 2,468,261
SCHEDULE OF FOREIGN CURRENCY RISK	SCHEDULE OF FOREIGN CURRENCY RISK April 30, 2022 CA$ Cash 208,683 Other receivables 64,930 Accounts payable and accrued liabilities (1,511,845 ) Due to related parties (765,409 ) Total (2,003,641 )

SEGMENTED INFORMATION (Tables)

SEGMENTED INFORMATION (Tables)	6 Months Ended
	Apr. 30, 2022
Segment Reporting [Abstract]
SCHEDULE OF ASSETS INFORMATION	SCHEDULE OF ASSETS INFORMATION April 30, 2022 October 31, 2021 $ $ Canada – property, plant and equipment 3,946,315 2,546,383 United States – property, plant and equipment 31,304 28,321 United States – mineral property costs 93,453 93,453 Property, plant and equipment net 4,071,072 2,668,157 Canada – other assets 392,853 1,554,827 United States – other assets 1,611,578 290,528 Other assets 2,004,431 1,845,355 Total Assets 6,075,503 4,513,512

NATURE OF OPERATIONS AND GOIN_2

NATURE OF OPERATIONS AND GOING CONCERN (Details Narrative) - USD ($)	6 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Retained Earnings (Accumulated Deficit)	$ 65,894,907		$ 52,129,621
Working capital deficit	7,172,573		$ 9,657,316
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest	13,551,323	$ 2,745,438
Cash	$ 4,000,000

SCHEDULE OF PROPERTY, PLANT AND

SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)	6 Months Ended		12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Oct. 31, 2021	Oct. 31, 2020
Property, Plant and Equipment [Line Items]
Balance, October 31, 2021	$ 2,647,378	$ 107,257	$ 107,257
Additions	1,601,999		2,496,927
Write-off of equipment			(4,245)
Foreign exchange effect	(76,405)		47,439
Balance, April 30, 2022	4,172,972		2,647,378
Balance, October 31, 2021	72,674	27,821	27,821
Depreciation expense	123,961	8,645	44,148
Write-off of equipment			(2,057)
Foreign exchange effect	(1,282)		2,762
Balance, April 30, 2022	195,353		72,674
Net book value	3,977,619		2,574,704	$ 79,436
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Balance, October 31, 2021	109,629	32,318	32,318
Additions	7,008		77,955
Write-off of equipment			(4,245)
Foreign exchange effect			3,601
Balance, April 30, 2022	116,637		109,629
Balance, October 31, 2021	27,821	14,677	14,677
Depreciation expense	18,236		13,907
Write-off of equipment			(2,057)
Foreign exchange effect			1,294
Balance, April 30, 2022	46,057		27,821
Net book value	70,580		81,808	17,641
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Balance, October 31, 2021	53,542	38,916	38,916
Additions	2,171		11,510
Write-off of equipment
Foreign exchange effect	(288)		3,116
Balance, April 30, 2022	55,425		53,542
Balance, October 31, 2021	16,514	8,326	8,326
Depreciation expense	3,833		7,443
Write-off of equipment
Foreign exchange effect	(48)		745
Balance, April 30, 2022	20,299		16,514
Net book value	35,126		37,028	30,590
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Balance, October 31, 2021	139,481	7,610	7,610
Additions	107,014		129,257
Write-off of equipment
Foreign exchange effect	(5,306)		2,614
Balance, April 30, 2022	241,189		139,481
Balance, October 31, 2021	14,147	4,818	4,818
Depreciation expense	15,217		8,827
Write-off of equipment
Foreign exchange effect	(404)		502
Balance, April 30, 2022	28,960		14,147
Net book value	212,229		125,334	2,792
Furnace and Plant Equipment [Member]
Property, Plant and Equipment [Line Items]
Balance, October 31, 2021	2,344,726	28,413	28,413
Additions	1,456,591		2,278,205
Write-off of equipment
Foreign exchange effect	(70,509)		38,108
Balance, April 30, 2022	3,730,808		2,344,726
Balance, October 31, 2021	14,192
Depreciation expense	83,755		13,971
Write-off of equipment
Foreign exchange effect	(801)		221
Balance, April 30, 2022	97,146		14,192
Net book value	3,633,662		2,330,534	28,413
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Balance, October 31, 2021
Additions	29,215
Write-off of equipment
Foreign exchange effect	(302)
Balance, April 30, 2022	28,913
Balance, October 31, 2021
Depreciation expense	2,920
Write-off of equipment
Foreign exchange effect	(29)
Balance, April 30, 2022	2,891
Net book value	$ 26,022

SCHEDULE OF RIGHT- OF - USE ASS

SCHEDULE OF RIGHT- OF - USE ASSETS (Details) - USD ($)	6 Months Ended		12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Oct. 31, 2021	Oct. 31, 2020
Balance, October 31, 2021	$ 858,798	$ 440,506	$ 440,506
Additions			379,084
Foreign exchange effect	(15,316)		39,208
Balance, April 30, 2022	843,482		858,798
Balance, October 31, 2021	260,223	66,519	66,519
Depreciation expense	118,366	88,348	185,754
Foreign exchange effect	(4,928)		7,950
Balance, April 30, 2022	373,661		260,223
Net book value	469,821		598,575	$ 373,987
Vancouver Office [Member]
Balance, October 31, 2021	156,881	59,701	59,701
Additions			91,237
Foreign exchange effect			5,943
Balance, April 30, 2022	156,881		156,881
Balance, October 31, 2021	90,277	42,142	42,142
Depreciation expense	22,229		44,259
Foreign exchange effect			3,876
Balance, April 30, 2022	112,506		90,277
Net book value	44,375		66,604	17,559
Virginia Office [Member]
Balance, October 31, 2021	292,391
Additions			287,847
Foreign exchange effect	(3,038)		4,544
Balance, April 30, 2022	289,353		292,391
Balance, October 31, 2021	15,529
Depreciation expense	33,790		15,288
Foreign exchange effect	(162)		241
Balance, April 30, 2022	49,157		15,529
Net book value	240,196		276,862
Nevada Office [Member]
Balance, October 31, 2021	24,580	22,856	22,856
Additions
Foreign exchange effect			1,724
Balance, April 30, 2022	24,580		24,580
Balance, October 31, 2021	24,580	14,434	14,434
Depreciation expense			8,915
Foreign exchange effect			1,231
Balance, April 30, 2022	24,580		24,580
Net book value				8,422
Pilot Plant [Member]
Balance, October 31, 2021	384,946	357,949	357,949
Additions
Foreign exchange effect	(12,278)		26,997
Balance, April 30, 2022	372,668		384,946
Balance, October 31, 2021	129,837	$ 9,943	9,943
Depreciation expense	62,347		117,292
Foreign exchange effect	(4,766)		2,602
Balance, April 30, 2022	187,418		129,837
Net book value	$ 185,250		$ 255,109	$ 348,006

SCHEDULE OF OPERATING LEASE (De

SCHEDULE OF OPERATING LEASE (Details) - USD ($)	6 Months Ended	12 Months Ended
	Apr. 30, 2022	Oct. 31, 2021
Balance, October 31, 2021	$ 584,325	$ 380,927
Additions		351,886
Lease payments	(93,244)	(201,562)
Interest expense	17,899	25,319
Prior period adjustment		(3,065)
Foreign exchange effect	(10,241)	30,820
Balance, April 30, 2022	498,739	584,325
Current lease obligation	244,592	192,045
Non-current lease obligation	254,147	392,280
Vancouver Office [Member]
Balance, October 31, 2021	66,604	18,123
Additions		91,237
Lease payments	(24,187)	(47,931)
Interest expense	1,958	3,076
Prior period adjustment
Foreign exchange effect		2,099
Balance, April 30, 2022	44,375	66,604
Current lease obligation	44,375
Non-current lease obligation
Virginia Office [Member]
Balance, October 31, 2021	262,612
Additions		260,649
Lease payments		(5,137)
Interest expense	9,230	3,019
Prior period adjustment
Foreign exchange effect	(2,728)	4,081
Balance, April 30, 2022	269,114	262,612
Current lease obligation	71,092
Non-current lease obligation	198,022
Nevada Office [Member]
Balance, October 31, 2021		12,211
Additions
Lease payments		(9,457)
Interest expense		219
Prior period adjustment		(3,065)
Foreign exchange effect		92
Balance, April 30, 2022
Current lease obligation
Non-current lease obligation
Pilot Plant [Member]
Balance, October 31, 2021	255,109	350,593
Additions
Lease payments	(69,057)	(139,037)
Interest expense	6,711	19,005
Prior period adjustment
Foreign exchange effect	(7,513)	24,548
Balance, April 30, 2022	185,250	$ 255,109
Current lease obligation	129,125
Non-current lease obligation	$ 56,125

LEASE OBLIGATIONS (Details Narr

LEASE OBLIGATIONS (Details Narrative) - USD ($)	Apr. 30, 2022	Oct. 31, 2021	Oct. 31, 2020	Nov. 02, 2019
Operating lease, liability	$ 498,739	$ 584,325	$ 380,927	$ 83,549
Lessee, operating lease, discount rate				7.00%
British Columbia [Member]
Operating lease, liability		$ 91,237	$ 354,263
Lessee, operating lease, discount rate		7.00%	6.00%
McLean,Virginia [Member]
Operating lease, liability		$ 260,649
Lessee, operating lease, discount rate		7.00%

MINERAL PROPERTY COSTS (Details

MINERAL PROPERTY COSTS (Details Narrative)	Apr. 30, 2022USD ($)aha	Oct. 31, 2021USD ($)
Reserve Quantities [Line Items]
Mineral properties, net	$ 93,453	$ 93,453
Silverado Property [Member]
Reserve Quantities [Line Items]
Area of land | ha	120
Ownership percentage	100.00%
Carrying value of property	$ 1
TamiMosi Property [Member]
Reserve Quantities [Line Items]
Ownership percentage	100.00%
Royalty percentage	2.00%
Mineral properties, net	$ 93,452
TamiMosi Property [Member] | White Pine County [Member]
Reserve Quantities [Line Items]
Area of land | a	1,637
TamiMosi Property [Member] | Moor Mining District [Member]
Reserve Quantities [Line Items]
Area of land | a	10

SCHEDULE OF DEPOSITS HELD BY RE

SCHEDULE OF DEPOSITS HELD BY RELATED PARTY (Details) - USD ($)		6 Months Ended	12 Months Ended
		Apr. 30, 2022	Oct. 31, 2021
Related Party Transaction [Line Items]
Balance, October 31, 2021		$ 486,462
Advances		1,556,048	3,280,824
Costs and expenses		(1,670,701)	(2,794,362)
Foreign exchange effect		16,948
Balance, April 30, 2022		388,757	486,462
Related Party A [Member]
Related Party Transaction [Line Items]
Balance, October 31, 2021	[1]	291,481
Advances	[1]	330,930	987,912
Costs and expenses	[1]	(249,872)	(696,431)
Foreign exchange effect	[1]	16,218
Balance, April 30, 2022	[1]	388,757	291,481
Related Party B [Member]
Related Party Transaction [Line Items]
Balance, October 31, 2021	[2]	194,981
Advances	[2]	1,225,118	2,292,912
Costs and expenses	[2]	(1,420,829)	(2,097,931)
Foreign exchange effect	[2]	730
Balance, April 30, 2022	[2]		$ 194,981
[1]	Related Party A is a company controlled by a director and officer.
[2]	Related Party B is a company controlled by an officer.

SCHEDULE OF DUE TO RELATED PART

SCHEDULE OF DUE TO RELATED PARTIES (Details) - USD ($)	Apr. 30, 2022	Oct. 31, 2021
Related Party Transactions [Abstract]
Wages payable to directors and officers	$ 357,500	$ 357,500
Benefits payable to directors and officers	730,810	539,209
Fees and expenses payable to directors and officers	164,970	127,878
Interest due to a shareholder		2,230
Total	$ 1,253,280	$ 1,026,817

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative)	Nov. 03, 2021USD ($)shares	Sep. 12, 2018	Aug. 28, 2018USD ($)	Jun. 30, 2021USD ($)	Jun. 30, 2021CAD ($)	Apr. 30, 2022USD ($)	Apr. 30, 2022CAD ($)	Apr. 30, 2021USD ($)	Nov. 03, 2021CAD ($)$ / shares	Oct. 31, 2021USD ($)
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Due to related parties						$ 1,253,280				$ 1,026,817
Stock based compensation						3,100,000
Number of common stock issued						546,697		$ 2,024,442
Directors and Officers [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Salaries management and consulting fees						1,626,279
Directors and Officers [Member] | Sublease Agreement [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Lease description				lease term from April 1, 2021 to March 31, 2023	lease term from April 1, 2021 to March 31, 2023
Payments for rent				$ 7,656	$ 9,794
Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock based compensation						160,700
Management [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Consulting fees						27,630	$ 35,000
Executive Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Consulting fees						$ 30,000
Director and Officer [Member] | Related Party Agreement [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Equity method investment, ownership percentage		5.00%
Number of common stock issued			$ 5,000,000
Number of common stock issued, shares | shares	9,163,425
Share price | $ / shares									$ 0.65
Fair value of share issue	$ 4,796,832								$ 5,956,226

CONTINGENT LIABILITIES AND CO_2

CONTINGENT LIABILITIES AND COMMITMENTS (Details Narrative) $ / shares in Units, shares in Millions

Mar. 04, 2022USD ($)

Feb. 08, 2021USD ($)shares

Feb. 08, 2021CAD ($)shares

Dec. 31, 2020USD ($)

Dec. 31, 2020CAD ($)

Sep. 29, 2020USD ($)

Sep. 30, 2021USD ($)

Jun. 30, 2021USD ($)

Jun. 30, 2021CAD ($)

Apr. 30, 2022USD ($)

Apr. 30, 2022CAD ($)

Apr. 30, 2021USD ($)shares

Oct. 31, 2020USD ($)

Oct. 31, 2020CAD ($)

Apr. 22, 2022CAD ($)

Nov. 03, 2021$ / shares

Oct. 31, 2021USD ($)

Apr. 19, 2021USD ($)

Nov. 01, 2016USD ($)

Nov. 01, 2016CAD ($)$ / shares

Loss Contingencies [Line Items]

Loss Contingency, Damages Sought, Value

$ 3,900,000

$ 4,900,000

$ 3,400,000

$ 4,200,000

Debt instrument, face amount

$ 100,000

Number of shares issued price per share | $ / shares

$ 0.65

Cash

$ 4,000,000

Payments for (Proceeds from) Tenant Allowance

41,010

Lodestar Management Group LLC [Member]

Loss Contingencies [Line Items]

Debt instrument, face amount

32,716

$ 53,491

Commitment of cash or arrangments amount

$ 1,800

$ 2,500

Number of shares issued price per share | $ / shares

$ 0.05

Issuance of share based minimum requirement

1,800

$ 2,500

Cash

$ 30,624

Number of shares issued | shares

Lampert Agreement [Member]

Loss Contingencies [Line Items]

Debt instrument, face amount

$ 367,227

Debt Instrument, Interest Rate, Effective Percentage

9.00%

Lease Agreement [Member]

Loss Contingencies [Line Items]

Loss Contingency, Damages Sought, Value

$ 120,000

Lessee, Operating Lease, Description

lease term from September 14, 2021 to February 28, 2025

lease term from October 1, 2020 to September 30, 2023

lease term from October 1, 2020 to September 30, 2023

Payments for Rent

$ 9,113

$ 16,194

$ 20,715

Sublease Agreement [Member] | Directors and Officers [Member]

Loss Contingencies [Line Items]

Lessee, Operating Lease, Description

lease term from April 1, 2021 to March 31, 2023

lease term from April 1, 2021 to March 31, 2023

Payments for Rent

$ 7,656

$ 9,794

Maximum [Member]

Loss Contingencies [Line Items]

Loss Contingency, Damages Sought, Value

$ 2,500,000

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares

33

33

PROMISSORY NOTE (Details Narrat

PROMISSORY NOTE (Details Narrative)	6 Months Ended		12 Months Ended
	Apr. 30, 2022USD ($)	Apr. 30, 2021USD ($)	Oct. 31, 2021USD ($)	Oct. 31, 2020USD ($)	Oct. 31, 2020CAD ($)	Oct. 31, 2019USD ($)	Oct. 31, 2019CAD ($)
Short-Term Debt [Line Items]
Repayments of debt		$ 64,993
Promissory Note [Member]
Short-Term Debt [Line Items]
Related party loan				$ 44,588	$ 60,000	$ 112,895	$ 150,000
Percentage of unsecured loan interest						18.00%	18.00%
Additional increase in promissory note loan				$ 157,483	$ 210,000
Maturity date				Sep. 24, 2021	Sep. 24, 2021
Interest and debt expense			$ 1,639	$ 16,655
Repayments of debt			$ 65,761	$ 101,066

PROVISION FOR FLOW THROUGH SH_2

PROVISION FOR FLOW THROUGH SHARE ISSUANCES (Details Narrative) - USD ($)	Apr. 30, 2022	Oct. 31, 2021
Provision For Flow Through Share Issuances
Provision for tax and related obligations	$ 225,833	$ 233,285

SCHEDULE OF DERIVATIVE INSTRUME

SCHEDULE OF DERIVATIVE INSTRUMENTS (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 30, 2022	Apr. 30, 2021	Apr. 30, 2022	Apr. 30, 2021	Oct. 31, 2021
Short-Term Debt [Line Items]
Accretion and interest expense	$ 326,868	$ 17,760	$ 649,148	$ 36,334
Foreign currency translation	49,183	(114,645)	213,963	(191,049)
Fair value adjustment	4,858,644	$ 31,190	(6,701,147)	16,656
Amortization			600,771
Debt Host Liability [Member]
Short-Term Debt [Line Items]
Balance, beginning			107	96,318	$ 96,318
Value of debt host liability recognized					1
Accretion and interest expense			50,819		23,693
Conversion			(628,031)		(125,560)
Foreign currency translation			(82)		5,655
Effects of functional currency change			1,500,000
Inception			2,000,000
Balance, ending	2,922,813		2,922,813		107
Debt Host Liability [Member] | July 2020 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning				96,318	96,318
Value of debt host liability recognized
Accretion and interest expense					23,587
Conversion					(125,560)
Foreign currency translation					5,655
Effects of functional currency change
Inception
Balance, ending
Debt Host Liability [Member] | July 2021 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning			63
Value of debt host liability recognized
Accretion and interest expense			28,050		63
Conversion			(28,031)
Foreign currency translation			(82)
Effects of functional currency change
Inception
Balance, ending					63
Debt Host Liability [Member] | April 2022 Convertible debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning
Value of debt host liability recognized
Accretion and interest expense			17,159
Conversion
Foreign currency translation
Effects of functional currency change
Inception			2,000,000
Balance, ending	2,017,159		2,017,159
Debt Host Liability [Member] | June 2021 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning			44
Value of debt host liability recognized					1
Accretion and interest expense			5,610		43
Conversion			(600,000)
Foreign currency translation
Effects of functional currency change			1,500,000
Inception
Balance, ending	905,654		905,654		44
Embedded Derivative Liability [Member]
Short-Term Debt [Line Items]
Balance, beginning			7,449,700	20,123	20,123
Conversion			(158,169)		(5,247)
Foreign currency translation			(3,478)		86,954
Effects of functional currency change			(7,028,606)
Balance, ending					7,449,700
Fair value of embedded derivative liability recognized					1,646,600
Fair value adjustment			(259,447)		5,701,270
Embedded Derivative Liability [Member] | July 2020 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning				20,123	20,123
Conversion					(5,247)
Foreign currency translation					1,182
Effects of functional currency change
Balance, ending
Fair value of embedded derivative liability recognized
Fair value adjustment					(16,058)
Embedded Derivative Liability [Member] | July 2021 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning
Conversion			(158,169)
Foreign currency translation			(3,478)
Effects of functional currency change			421,094
Balance, ending
Fair value of embedded derivative liability recognized
Fair value adjustment			(259,447)
Embedded Derivative Liability [Member] | April 2022 Convertible debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning
Conversion
Foreign currency translation
Effects of functional currency change
Balance, ending
Fair value of embedded derivative liability recognized
Fair value adjustment
Embedded Derivative Liability [Member] | June 2021 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning			7,449,700
Conversion
Foreign currency translation					85,772
Effects of functional currency change			(7,449,700)
Balance, ending					7,449,700
Fair value of embedded derivative liability recognized					1,646,600
Fair value adjustment					5,717,328
Debt Discount [Member]
Short-Term Debt [Line Items]
Effects of functional currency change			(1,500,000)
Balance, beginning
Inception			(240,000)
Amortization			600,771
Balance, ending	(1,139,229)		(1,139,229)
Debt Discount [Member] | July 2020 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Effects of functional currency change
Balance, beginning
Inception
Amortization
Balance, ending
Debt Discount [Member] | July 2021 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Effects of functional currency change
Balance, beginning
Inception
Amortization
Balance, ending
Debt Discount [Member] | April 2022 Convertible debenture [Member]
Short-Term Debt [Line Items]
Effects of functional currency change
Balance, beginning
Inception			(240,000)
Amortization			2
Balance, ending	(239,998)		(239,998)
Debt Discount [Member] | June 2021 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Effects of functional currency change			(1,500,000)
Balance, beginning
Inception
Amortization			600,769
Balance, ending	(899,231)		(899,231)
Combined Value of Convertible Debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning			7,449,807	116,441	116,441
Balance, ending	1,783,584		1,783,584		7,449,807
Combined Value of Convertible Debenture [Member] | July 2020 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning				116,441	116,441
Balance, ending
Combined Value of Convertible Debenture [Member] | July 2021 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning			63
Balance, ending					63
Combined Value of Convertible Debenture [Member] | April 2022 Convertible debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning			7,449,744
Balance, ending	1,777,161		1,777,161		7,449,744
Combined Value of Convertible Debenture [Member] | June 2021 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Balance, beginning			7,449,744
Balance, ending	$ 6,423		$ 6,423		$ 7,449,744

SCHEDULE OF OPTION PRICING MODE

SCHEDULE OF OPTION PRICING MODEL (Details)	6 Months Ended
	Apr. 30, 2022$ / shares	Apr. 30, 2021	Apr. 30, 2022$ / shares
Short-Term Debt [Line Items]
Expected life in years	5 years
Expected dividend rate
April 22, 2022 [Member]
Short-Term Debt [Line Items]
Risk free rate of interest	2.65%
Expected life in years	2 months 23 days
Conversion exercise price			$ 0.12
Underlying share price of the Company			0.36
Expected volatility	99.90%
Expected dividend rate
November 1, 2021 [Member]
Short-Term Debt [Line Items]
Risk free rate of interest	1.07%
Expected life in years	8 months 12 days
Conversion exercise price			0.12
Underlying share price of the Company			0.75
Expected volatility	124.34%
Expected dividend rate
October 31, 2021 [Member]
Short-Term Debt [Line Items]
Risk free rate of interest	1.08%
Expected life in years	1 year 1 month 9 days
Conversion exercise price	$ 0.10
Underlying share price of the Company	$ 0.59
Expected volatility	107.62%
Expected dividend rate
June 15, 2021 [Member]
Short-Term Debt [Line Items]
Risk free rate of interest	0.31%
Expected life in years	1 year 6 months
Conversion exercise price	$ 0.10
Underlying share price of the Company	$ 0.19
Expected volatility	87.17%
Expected dividend rate
July 27, 2021 [Member]
Short-Term Debt [Line Items]
Risk free rate of interest	0.26%
July 27, 2020 [Member]
Short-Term Debt [Line Items]
Expected life in years	8 months 26 days
Conversion exercise price			0.15
Underlying share price of the Company			$ 0.13
Expected volatility	82.54%
Expected dividend rate

CONVERTIBLE DEBENTURE AND DER_3

CONVERTIBLE DEBENTURE AND DERIVATIVE LIABILITY (Details Narrative)	Apr. 22, 2022CAD ($)$ / sharesshares	Apr. 14, 2022USD ($)$ / sharesshares	Jun. 15, 2021USD ($)shares	May 18, 2021USD ($)shares	Apr. 30, 2022USD ($)$ / sharesshares	Apr. 30, 2022CAD ($)shares	Apr. 30, 2021USD ($)shares	Oct. 31, 2021USD ($)shares	Apr. 30, 2022CAD ($)shares	Nov. 03, 2021$ / sharesshares	Nov. 02, 2021USD ($)	Jul. 15, 2021USD ($)	Jul. 15, 2021CAD ($)$ / shares	Jul. 27, 2020USD ($)	Jul. 27, 2020CAD ($)$ / shares
Short-Term Debt [Line Items]
Debt instrument, face amount	$ 100,000
Debt host liability share, face value | $ / shares										$ 0.65
Common stock, shares issued | shares	933,333				434,866,801			392,943,398	434,866,801	9,163,425
Common stock, value issued					$ 39,096,950			$ 29,842,167
Warrants exercisable price | $ / shares	$ 0.20
Contractual interest								70,521
Penalty cash					4,000,000
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature					240,000
Amortization of debt discount premium					600,771
Warrants [Member]
Short-Term Debt [Line Items]
Loss on recognition of debt liability					7,060,790
Derivative Liability					2,465,603						$ 26,956,177
Exercise of common share purchase warrants					4,482,962
Broker warrants [Member]
Short-Term Debt [Line Items]
Derivative Liability					$ 2,658						$ 76,811
Common Stock [Member]
Short-Term Debt [Line Items]
Number of shares issued | shares					1,375,499	1,375,499	25,724,955
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
July 2020 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount														$ 112,124	$ 150,000
Debt instrument, interest rate percentage														12.00%	12.00%
Debt host liability share, face value | $ / shares															$ 0.15
Common stock, shares issued | shares				1,360,959
Conversion of stock, shares issued | shares				263,973
Common stock, value issued				$ 26,286
Effective interest rate percentage				37.00%
Number of shares issued | shares				1,360,959
Debt instrument, fair value					87,083
Embedded derivative liability					25,041
July 2021 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount												$ 79,542	$ 100,000
Debt instrument, interest rate percentage												12.00%	12.00%
Conversion of stock, shares issued | shares	933,333
Effective interest rate percentage	594.00%
Debt instrument, conversion price | $ / shares													$ 0.12
Warrants exercisable price | $ / shares													$ 0.20
Convertible debenture face value					79,542	$ 100,000
Embedded Derivative, Fair Value of Embedded Derivative Liability					421,095				$ 529,400
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature					$ 341,553	$ 429,400
June 2021 Convertible Debenture [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount			$ 1,500,000
Debt instrument, interest rate percentage			12.00%
Debt host liability share, face value | $ / shares					$ 1
Debt instrument maturity date			Dec. 10, 2022
Conversion of convertiable debenture | shares			15,000,000
Debt conversion, description					(i) one share of the Company’ common stock, (ii) one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being exercisable at a price of $0.19 until June 10, 2026 (collectively, the “Class A and B Warrants”). In addition, the conversion price for accrued interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSX-V at the time of conversion	(i) one share of the Company’ common stock, (ii) one-half of one Class A common stock purchase warrant, with each whole warrant being exercisable at a price of $0.13 until June 10, 2026, and (iii) one-half of one Class B common stock purchase warrant, with each whole warrant being exercisable at a price of $0.19 until June 10, 2026 (collectively, the “Class A and B Warrants”). In addition, the conversion price for accrued interest is the greater of (i) $0.10 and (ii) the minimum conversion price permitted by the TSX-V at the time of conversion
Number of shares issued | shares					6,000,000	6,000,000
Contractual interest					$ 140,942
Debt instrument interest rate description					effective interest rate of 1,240	effective interest rate of 1,240
Debt instrument, fair value					$ 1,500,000
Embedded derivative liability					1,646,600
Loss on recognition of debt liability					146,601
Convertible debt combined value								7,449,744
Amortization of debt discount premium					600,769
Debt discount carry value					$ 899,231
June 2021 Convertible Debenture [Member] | Common Class A [Member]
Short-Term Debt [Line Items]
Warrants exercisable price | $ / shares					$ 0.13
Number of warrants exercisable | shares					3,000,000				3,000,000
June 2021 Convertible Debenture [Member] | Common Class B [Member]
Short-Term Debt [Line Items]
Warrants exercisable price | $ / shares					$ 0.19
Number of warrants exercisable | shares					3,000,000				3,000,000
June 2021 Convertible Debenture [Member] | Common Stock [Member]
Short-Term Debt [Line Items]
Number of shares issued | shares					6,000,000	6,000,000
April 2022 Convertible debenture [Member]
Short-Term Debt [Line Items]
Debt instrument, face amount		$ 2,000,000
Debt instrument, interest rate percentage		15.00%
Effective interest rate percentage					22.00%				22.00%
Debt instrument maturity date		Oct. 14, 2023
Contractual interest					$ 13,151
Penalty cash		$ 20,000
Convertible debenture face value					240,000
Debt discount carry value					239,998
Interest expense					$ 2
April 2022 Convertible debenture [Member] | Common Stock [Member]
Short-Term Debt [Line Items]
Warrants exercisable price | $ / shares		$ 0.40
Number of shares issued | shares		6,666,667

SUMMARY OF CHANGES IN COMMON SH

SUMMARY OF CHANGES IN COMMON SHARE PURCHASE WARRANTS (Details)	6 Months Ended
	Apr. 30, 2022$ / sharesshares	Apr. 30, 2022$ / shares$ / sharesshares	Apr. 30, 2021$ / sharesshares		Apr. 30, 2022$ / shares	Apr. 22, 2022$ / shares
Class of Warrant or Right [Line Items]
Exercise price | $ / shares						$ 0.20
Purchase Warrant One [Member]
Class of Warrant or Right [Line Items]
Beginning balance	59,548,982	59,548,982
Granted	933,333	933,333
Exercised	(23,701,146)	(23,701,146)
Expired/Cancelled	(5,660,296)	(5,660,296)
Ending balance	31,120,873	31,120,873
Weighted average exercise price, beginning | $ / shares		$ 0.22
Weighted average exercise price, granted | $ / shares		0.20
Weighted average exercise price, exercised | $ / shares		0.18
Weighted average exercise price, expired/cancelled | $ / shares		0.16
Weighted average exercise price, ending | $ / shares		$ 0.26
Purchase Warrant Two [Member]
Class of Warrant or Right [Line Items]
Beginning balance
Granted	7,375,499	7,375,499
Exercised
Expired/Cancelled
Ending balance	4,375,499	4,375,499
Weighted average exercise price, beginning | $ / shares
Weighted average exercise price, granted | $ / shares	0.27
Weighted average exercise price, exercised | $ / shares
Weighted average exercise price, expired/cancelled | $ / shares
Weighted average exercise price, ending | $ / shares	$ 0.27
Purchase Warrant [Member]
Class of Warrant or Right [Line Items]
Beginning balance	59,548,982	59,548,982	10,109,642
Granted	8,308,832	8,308,832	25,724,955
Exercised	(23,701,146)	(23,701,146)	(400,000)
Expired/Cancelled	(5,660,296)	(5,660,296)
Ending balance	38,496,372	38,496,372	35,434,597
Weighted average exercise price, beginning | $ / shares			$ 0.11
Weighted average exercise price, granted | $ / shares			0.19
Weighted average exercise price, exercised | $ / shares			0.05
Weighted average exercise price, expired/cancelled | $ / shares
Weighted average exercise price, ending | $ / shares			$ 0.17
November 22, 2021 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Nov. 22, 2021	Nov. 22, 2021	Nov. 22, 2021
Beginning balance	4,160,021	4,160,021
Granted			5,599,171
Exercised	(4,080,573)	(4,080,573)
Expired/Cancelled	(79,448)	(79,448)
Ending balance			5,599,171
Exercise price | $ / shares			$ 0.19	[1]	$ 0.19
Weighted Average Life (Years)			6 months 21 days
January 17, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Jan. 17, 2022	Jan. 17, 2022	Jan. 17, 2022
Beginning balance	7,267,914	7,267,914
Granted			7,337,914
Exercised	(5,959,396)	(5,959,396)
Expired/Cancelled	(1,308,518)	(1,308,518)
Ending balance			7,337,914
Exercise price | $ / shares			$ 0.19	[1]	0.19
Weighted Average Life (Years)			8 months 15 days
January 31, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Jan. 31, 2022	Jan. 31, 2022	Jan. 31, 2022
Beginning balance	5,382,303	5,382,303
Granted			5,382,303
Exercised	(4,341,906)	(4,341,906)
Expired/Cancelled	(1,040,397)	(1,040,397)
Ending balance			5,382,303
Exercise price | $ / shares			$ 0.19	[1]	0.19
Weighted Average Life (Years)			9 months
February 21, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Feb. 21, 2022	Feb. 21, 2022	Feb. 21, 2022
Beginning balance	1,505,200	1,505,200	1,505,200
Granted
Exercised	(200,000)	(200,000)
Expired/Cancelled	(1,305,200)	(1,305,200)
Ending balance			1,505,200
Exercise price | $ / shares			$ 0.05	[1]	0.05
Weighted Average Life (Years)			9 months 21 days
March 24, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Mar. 24, 2022	Mar. 24, 2022	Mar. 24, 2022
Beginning balance	6,341,872	6,341,872
Granted			6,554,172
Exercised	(4,515,139)	(4,515,139)
Expired/Cancelled	(1,826,733)	(1,826,733)
Ending balance			6,554,172
Exercise price | $ / shares			$ 0.19	[1]	0.19
Weighted Average Life (Years)			10 months 24 days
March 27, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Mar. 27, 2022	Mar. 27, 2022	Mar. 27, 2022
Beginning balance	982,025	982,025	1,482,025
Granted
Exercised	(882,025)	(882,025)
Expired/Cancelled	(100,000)	(100,000)
Ending balance			1,482,025
Exercise price | $ / shares			$ 0.05	[1]	0.05
Weighted Average Life (Years)			10 months 28 days
April 27, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Apr. 27, 2022	Apr. 27, 2022	Apr. 27, 2022
Beginning balance	791,395	791,395
Granted			851,395
Exercised	(791,395)	(791,395)
Expired/Cancelled
Ending balance			851,395
Exercise price | $ / shares			$ 0.19	[1]	0.19
Weighted Average Life (Years)			11 months 26 days
May 9, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	May 9, 2022	May 9, 2022	May 9, 2022
Beginning balance	1,813,725	1,813,725	2,368,626
Granted
Exercised	(1,000,000)	(1,000,000)
Expired/Cancelled
Ending balance	813,725	813,725	2,368,626
Exercise price | $ / shares			$ 0.05	[1]	$ 0.05
Weighted Average Life (Years)	7 days	7 days	1 year 7 days		7 days
May 30, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	May 30, 2022	May 30, 2022
Beginning balance	5,223,420	5,223,420
Granted
Exercised	(276,675)	(276,675)
Expired/Cancelled
Ending balance	4,946,745	4,946,745
Exercise price | $ / shares					$ 0.19
Weighted Average Life (Years)	29 days	29 days			29 days
June 17, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Jun. 17, 2022	Jun. 17, 2022
Beginning balance	17,703,506	17,703,506
Granted
Exercised	(1,393,077)	(1,393,077)
Expired/Cancelled
Ending balance	16,310,429	16,310,429
Exercise price | $ / shares					$ 0.19
Weighted Average Life (Years)	1 month 17 days	1 month 17 days			1 month 17 days
July 18, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Jul. 18, 2022	Jul. 18, 2022
Beginning balance	4,350,000	4,350,000
Granted
Exercised	(60,960)	(60,960)
Expired/Cancelled
Ending balance	4,289,040	4,289,040
Exercise price | $ / shares					$ 0.30
Weighted Average Life (Years)	2 months 19 days	2 months 19 days			2 months 19 days
August 14, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Aug. 14, 2022	Aug. 14, 2022	Aug. 14, 2022
Beginning balance	200,000	200,000	1,110,000
Granted
Exercised	(200,000)	(200,000)	(400,000)
Expired/Cancelled
Ending balance			710,000
Exercise price | $ / shares			$ 0.05	[1]	$ 0.05
Weighted Average Life (Years)	3 months 14 days	3 months 14 days	1 year 3 months 14 days		3 months 14 days
February 13, 2023 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Feb. 13, 2023	Feb. 13, 2023
Beginning balance	3,827,601	3,827,601
Granted
Exercised
Expired/Cancelled
Ending balance	3,827,601	3,827,601
Exercise price | $ / shares					$ 0.65
Weighted Average Life (Years)	9 months 14 days	9 months 14 days			9 months 14 days
April 22, 2024 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Apr. 22, 2024	Apr. 22, 2024
Beginning balance
Granted	933,333	933,333
Exercised
Expired/Cancelled
Ending balance	933,333	933,333
Exercise price | $ / shares					$ 0.20
Weighted Average Life (Years)	1 year 11 months 23 days	1 year 11 months 23 days			1 year 11 months 23 days
November 27, 2022 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Nov. 27, 2022	Nov. 27, 2022
Beginning balance
Granted	1,375,499	1,375,499
Exercised
Expired/Cancelled
Ending balance	1,375,499	1,375,499
Exercise price | $ / shares	$ 0.75	$ 0.75
Weighted Average Life (Years)	6 months 29 days	6 months 29 days			6 months 29 days
June 10, 2026 [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Jun. 10, 2026	Jun. 10, 2026
Beginning balance
Granted	3,000,000	3,000,000
Exercised
Expired/Cancelled
Ending balance	1,500,000	1,500,000
Exercise price | $ / shares	$ 0.13	$ 0.13
Weighted Average Life (Years)	4 years 1 month 13 days	4 years 1 month 13 days			4 years 1 month 13 days
June 10, 2026 One [Member]
Class of Warrant or Right [Line Items]
Expiry Date	Jun. 10, 2026	Jun. 10, 2026
Beginning balance
Granted	3,000,000	3,000,000
Exercised
Expired/Cancelled
Ending balance	1,500,000	1,500,000
Exercise price | $ / shares	$ 0.19	$ 0.19
Weighted Average Life (Years)	4 years 1 month 13 days	4 years 1 month 13 days			4 years 1 month 13 days
August 31, 2021 [Member]
Class of Warrant or Right [Line Items]
Expiry Date			Aug. 31, 2021	[1]
Beginning balance			3,643,791
Granted
Exercised
Expired/Cancelled
Ending balance			3,643,791
Exercise price | $ / shares			$ 0.21	[1]
Weighted Average Life (Years)			4 months 2 days
[1]	The Company received approval of the TSX-V on January 13, 2021 and amended the expiry date of 3,643,791 extending the expiry date from January 17, 2021 to August 31, 2021 0.30

SUMMARY OF CHANGES IN COMMON _2

SUMMARY OF CHANGES IN COMMON SHARE PURCHASE WARRANTS (Details) (Parenthetical)	Jan. 13, 2021$ / sharesshares	Apr. 30, 2022$ / shares	Oct. 31, 2021$ / shares
Equity [Abstract]
Class of warrant or right outstanding	3,643,791
Maturity date, description	extending the expiry date from January 17, 2021 to August 31, 2021
Common stock par or stated value per share | (per share)	$ 0.30	$ 0.001	$ 0.001

SCHEDULE OF FAIR VALUE ASSUMPTI

SCHEDULE OF FAIR VALUE ASSUMPTIONS (Details) - $ / shares	6 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Risk free rate of interest, minimum	1.34%	0.20%
Risk free rate of interest, maximum	2.59%	1.07%
Expected life of options	5 years
Expected annualized volatility, minimum	134.93%	130.88%
Expected annualized volatility, maximum	136.08%	140.05%
Expected dividend rate
Minimum [Member]
Expected life of options		2 years
Exercise price of options	$ 0.40	$ 0.13
Maximum [Member]
Expected life of options		5 years
Exercise price of options	$ 0.58	$ 0.70

SCHEDULE OF STOCK OPTIONS ACTIV

SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)	6 Months Ended				12 Months Ended
	Apr. 30, 2022USD ($)shares	Apr. 30, 2022$ / shares	Apr. 30, 2021USD ($)shares	Apr. 30, 2021$ / shares	Oct. 31, 2021USD ($)shares	Oct. 31, 2021$ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total outstanding, beginning balance	61,260,000		28,420,000		28,420,000
Total granted	1,250,000		15,650,000
Stock issued during period shares stock options exercised	750,000		100,000
Total expired, cancelled	(4,250,000)		(17,250,000)
Total outstanding, ending balance	57,510,000		26,720,000		61,260,000
Total vested	57,360,000		26,720,000
Weighted average remaining life, outstanding	3 years 1 month 24 days		2 years 9 months 10 days
Total exercised	(750,000)		(100,000)
Weighted average exercise price, beginning balance | $ / shares		$ 0.33		$ 0.09		$ 0.09
Weighted average exercise price, granted | $ / shares		0.44		0.13
Weighted average exercise price, exercised | $ / shares		0.05		0.05
Weighted average exercise price, expired/cancelled | $ / shares		0.11		0.13
Weighted average exercise price, ending balance | $ / shares		0.34		0.09		0.33
Weighted average exercise price, vested | $ / shares		0.33		0.09
Aggregate intrinsic value, outstanding | $	$ 19,994,025		$ 801,922		$ 801,922
Aggregate intrinsic value, outstanding | $	(2,149,050)		(597,721)		(19,994,025)
Aggregate intrinsic value, vested | $	$ (2,102,148)		$ (597,721)
Weighted average remaining life, outstanding	3 years 5 months 15 days		3 years 2 months 4 days
Weighted average remaining life, vested	3 years 1 month 24 days		2 years 9 months 10 days
Weighted average exercise price, ending balance | $ / shares		0.34		0.09		$ 0.33
Aggregate intrinsic value, outstanding | $	$ 2,149,050		$ 597,721		$ 19,994,025
Aggregate intrinsic value, vested | $	$ 2,102,148		$ 597,721
Option One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Mar. 27, 2022		Feb. 11, 2021
Share Price | $ / shares		0.05		0.05
Total outstanding, beginning balance	1,500,000		800,000		800,000
Total granted
Stock issued during period shares stock options exercised	(750,000)
Total expired, cancelled	(750,000)		(800,000)
Total outstanding, ending balance					1,500,000
Total vested
Weighted average remaining life, outstanding			10 days
Total exercised	750,000
Option Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Dec. 30, 2022		Aug. 16, 2021
Share Price | $ / shares		0.13		0.05
Total outstanding, beginning balance	6,000,000		600,000		600,000
Total granted
Stock issued during period shares stock options exercised
Total expired, cancelled	(150,000)
Total outstanding, ending balance	5,850,000		600,000		6,000,000
Total vested	5,850,000		600,000
Weighted average remaining life, outstanding	8 months 1 day		6 months 14 days
Total exercised
Option Three [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Aug. 12, 2023		Mar. 27, 2022
Share Price | $ / shares		0.05		0.05
Total outstanding, beginning balance	2,290,000		1,750,000		1,750,000
Total granted
Stock issued during period shares stock options exercised
Total expired, cancelled	(750,000)
Total outstanding, ending balance	1,540,000		1,750,000		2,290,000
Total vested	1,540,000		1,750,000
Weighted average remaining life, outstanding	1 year 3 months 10 days		1 year 1 month 24 days
Total exercised
Option Four [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Dec. 3, 2023		Aug. 26, 2022
Share Price | $ / shares		0.05		0.13
Total outstanding, beginning balance	6,450,000		500,000		500,000
Total granted
Stock issued during period shares stock options exercised
Total expired, cancelled	(1,000,000)		(500,000)
Total outstanding, ending balance	5,450,000				6,450,000
Total vested	5,450,000
Weighted average remaining life, outstanding	1 year 7 months 2 days
Total exercised
Option Five [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	May 22, 2024		Dec. 30, 2022
Share Price | $ / shares		0.12		0.13
Total outstanding, beginning balance	7,900,000
Total granted			6,150,000
Stock issued during period shares stock options exercised
Total expired, cancelled	(850,000)		(6,150,000)
Total outstanding, ending balance	7,050,000				7,900,000
Total vested	7,050,000
Weighted average remaining life, outstanding	2 years 21 days		1 year 10 months 28 days
Total exercised
Option Six [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Nov. 3, 2024		Apr. 19, 2023
Share Price | $ / shares		0.15		0.05
Total outstanding, beginning balance	700,000		800,000		800,000
Total granted
Stock issued during period shares stock options exercised
Total expired, cancelled
Total outstanding, ending balance	700,000		800,000		700,000
Total vested	700,000		800,000
Weighted average remaining life, outstanding	2 years 6 months 7 days		2 years 2 months 15 days
Total exercised
Option Seven [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Nov. 24, 2024		Aug. 12, 2023
Share Price | $ / shares		0.16		0.05
Total outstanding, beginning balance	320,000		3,120,000		3,120,000
Total granted
Stock issued during period shares stock options exercised			(100,000)
Total expired, cancelled	(300,000)
Total outstanding, ending balance	20,000		3,020,000		320,000
Total vested	20,000		3,020,000
Weighted average remaining life, outstanding	2 years 6 months 25 days		2 years 6 months 10 days
Total exercised			100,000
Option Eight [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Mar. 26, 2025		Dec. 3, 2023
Share Price | $ / shares		0.11		0.05
Total outstanding, beginning balance	100,000		7,000,000		7,000,000
Total granted
Stock issued during period shares stock options exercised
Total expired, cancelled
Total outstanding, ending balance	100,000		7,000,000		100,000
Total vested	100,000		7,000,000
Weighted average remaining life, outstanding	2 years 10 months 28 days		2 years 10 months 2 days
Total exercised
Option Nine [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Apr. 23, 2025		May 22, 2024
Share Price | $ / shares		0.12		0.12
Total outstanding, beginning balance	3,350,000		7,950,000		7,950,000
Total granted
Stock issued during period shares stock options exercised
Total expired, cancelled	(250,000)
Total outstanding, ending balance	3,100,000		7,950,000		3,350,000
Total vested	3,100,000		7,950,000
Weighted average remaining life, outstanding	2 years 11 months 23 days		3 years 3 months 21 days
Total exercised
Option Ten [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Dec. 30, 2025		Nov. 3, 2024
Share Price | $ / shares		0.13		0.15
Total outstanding, beginning balance	9,500,000		700,000		700,000
Total granted
Stock issued during period shares stock options exercised
Total expired, cancelled
Total outstanding, ending balance	9,500,000		700,000		9,500,000
Total vested	9,500,000		700,000
Weighted average remaining life, outstanding	3 years 8 months 1 day		3 years 9 months 3 days
Total exercised
Option Eleven [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Aug. 30, 2026		Nov. 24, 2024
Share Price | $ / shares		0.70		0.16
Total outstanding, beginning balance	21,700,000		900,000		900,000
Total granted
Stock issued during period shares stock options exercised
Total expired, cancelled	(200,000)
Total outstanding, ending balance	21,500,000		900,000		21,700,000
Total vested	21,350,000		900,000
Weighted average remaining life, outstanding	4 years 4 months 2 days		3 years 9 months 25 days
Total exercised
Option Twelve [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Oct. 1, 2026		Mar. 26, 2025
Share Price | $ / shares		0.50		0.11
Total outstanding, beginning balance	1,450,000		300,000		300,000
Total granted
Stock issued during period shares stock options exercised
Total expired, cancelled
Total outstanding, ending balance	1,450,000		300,000		1,450,000
Total vested	1,450,000		300,000
Weighted average remaining life, outstanding	4 years 5 months 1 day		4 years 1 month 24 days
Total exercised
Option Thirteen [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Dec. 3, 2026		Apr. 23, 2025
Share Price | $ / shares		0.58		0.12
Total outstanding, beginning balance			4,000,000		4,000,000
Total granted	250,000
Stock issued during period shares stock options exercised
Total expired, cancelled			(300,000)
Total outstanding, ending balance	250,000		3,700,000
Total vested	250,000		3,700,000
Weighted average remaining life, outstanding	4 years 7 months 6 days		4 years 2 months 23 days
Total exercised
Option Fourteen [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Mar. 7, 2027		Dec. 30, 2025
Share Price | $ / shares		0.40		$ 0.13
Total outstanding, beginning balance
Total granted	500,000		9,500,000
Stock issued during period shares stock options exercised
Total expired, cancelled			(9,500,000)
Total outstanding, ending balance	500,000
Total vested	500,000
Weighted average remaining life, outstanding	4 years 10 months 6 days		4 years 11 months 1 day
Total exercised
Option Fifteen [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Date	Apr. 8, 2027
Share Price | $ / shares		$ 0.40
Total outstanding, beginning balance
Total granted	500,000
Stock issued during period shares stock options exercised
Total expired, cancelled
Total outstanding, ending balance	500,000
Total vested	500,000
Weighted average remaining life, outstanding	4 years 11 months 8 days
Total exercised

SCHEDULE OF NONVESTED STOCK OPT

SCHEDULE OF NONVESTED STOCK OPTIONS (Details) - 6 months ended Apr. 30, 2022	USD ($)$ / sharesshares	$ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average grant date fair value per option, granted | $ / shares
Total nonvested, beginning balance	462,500
Total nonvested, granted
Total nonvested, vested	(312,500)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Total nonvested, ending balance	150,000
Total nonvested, expired, cancelled
Weighted average grant date fair value per option, beginning balance | $ / shares		0.39
Weighted average grant date fair value per option, vested | $ / shares		0.30
Weighted average grant date fair value per option, expired, cancelled | $ / shares
Weighted average grant date fair value per option, ending balance | $ / shares		0.56
Weighted average grant date fair value total, beginning balance | $	$ 144,131
Weighted average grant date fair value total, granted | $
Weighted average grant date fair value total, vested | $	$ 74,063
Weighted average grant date fair value total, expired, cancelled | $ / shares
Weighted average grant date fair value total, ending balance | $	$ 65,463
Option One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non vested Expiration Date	Dec. 30, 2022
Weighted average grant date fair value per option, granted | $ / shares		0.07
Total nonvested, beginning balance	162,500
Total nonvested, granted
Total nonvested, vested	(162,500)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Total nonvested, ending balance
Weighted average life (years)	1 year 1 month 28 days
Total nonvested, expired, cancelled
Option Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Non vested Expiration Date	Aug. 30, 2026
Weighted average grant date fair value per option, granted | $ / shares		$ 0.56
Total nonvested, beginning balance	300,000
Total nonvested, granted
Total nonvested, vested	(150,000)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Total nonvested, ending balance	150,000
Weighted average life (years)	4 years 9 months 29 days
Total nonvested, expired, cancelled

SHARE CAPITAL (Details Narrativ

SHARE CAPITAL (Details Narrative)	Apr. 30, 2022USD ($)$ / sharesshares	Apr. 08, 2022$ / sharesshares	Mar. 10, 2022$ / sharesshares	Mar. 07, 2022$ / sharesshares	Jan. 20, 2022USD ($)$ / sharesshares	Dec. 13, 2021$ / sharesshares	Dec. 03, 2021$ / sharesshares	Nov. 26, 2021USD ($)$ / sharesshares	Nov. 04, 2021$ / sharesshares	Oct. 01, 2021$ / sharesshares	Aug. 30, 2021$ / sharesshares	Aug. 11, 2021USD ($)shares	Aug. 11, 2021CAD ($)$ / sharesshares	Jul. 16, 2021USD ($)shares	Jul. 16, 2021CAD ($)$ / sharesshares	Jun. 17, 2021USD ($)shares	Jun. 17, 2021CAD ($)$ / sharesshares	Jun. 07, 2021USD ($)shares	May 28, 2021USD ($)shares	May 28, 2021CAD ($)$ / sharesshares	May 18, 2021USD ($)shares	May 05, 2021CAD ($)$ / shares	Apr. 27, 2021USD ($)shares	Apr. 27, 2021CAD ($)$ / sharesshares	Mar. 24, 2021USD ($)shares	Mar. 24, 2021CAD ($)$ / sharesshares	Jan. 29, 2021USD ($)shares	Jan. 29, 2021CAD ($)$ / sharesshares	Jan. 15, 2021USD ($)shares	Jan. 15, 2021CAD ($)shares	Dec. 30, 2020$ / sharesshares	Nov. 20, 2020USD ($)shares	Nov. 20, 2020CAD ($)$ / sharesshares	Aug. 08, 2018	Apr. 27, 2022$ / sharesshares	Jan. 31, 2022CAD ($)$ / sharesshares	Apr. 30, 2022USD ($)$ / sharesshares	Apr. 30, 2022CAD ($)shares	Jan. 31, 2022USD ($)	Jan. 31, 2022CAD ($)$ / sharesshares	Apr. 30, 2021USD ($)	Apr. 30, 2022USD ($)$ / sharesshares	Apr. 30, 2022CAD ($)$ / sharesshares	Apr. 30, 2021USD ($)shares	Apr. 30, 2021$ / shares	Oct. 31, 2021USD ($)$ / sharesshares	Oct. 31, 2021CAD ($)shares	Apr. 30, 2022$ / shares	Apr. 22, 2022CAD ($)$ / sharesshares	Nov. 03, 2021USD ($)shares	Nov. 03, 2021CAD ($)$ / sharesshares	Oct. 31, 2021$ / shares	Jun. 11, 2021shares	Jun. 07, 2021CAD ($)$ / shares	Feb. 08, 2021shares	Jan. 15, 2021$ / shares	Jan. 13, 2021$ / shares	Jul. 27, 2020USD ($)	Jul. 27, 2020CAD ($)$ / shares	Aug. 29, 2018USD ($)
Subsidiary, Sale of Stock [Line Items]
Common voting shares	1,000,000,000																																				1,000,000,000					1,000,000,000				1,000,000,000
Common stock par value | (per share)	$ 0.001																																				$ 0.001					$ 0.001				$ 0.001											$ 0.30
Shares issued, price per share | $ / shares																																																			$ 0.65
Common stock shares subscriptions | $	$ 388,701																																				$ 388,701					$ 388,701				$ 209,827
Fair value of assets																																																		$ 4,796,832	$ 5,956,226
Common stock, shares issued	434,866,801																																				434,866,801					434,866,801				392,943,398			933,333	9,163,425	9,163,425
Exercise of warrants price per share | $ / shares																																																	$ 0.20
Number of stock options granted																																										1,250,000	1,250,000	15,650,000
Common stock, value, issued | $	$ 39,096,950																																				$ 39,096,950					$ 39,096,950				$ 29,842,167
Stock Issued During Period, Shares, Conversion of Convertible Securities																																			2,000,000
Proceeds from issuance of common stock | $																																										3,851,614		$ 1,856,336
Principal amount | $																																																	$ 100,000
Accrued interest | $																																																	$ 12,000
Share based compensation | $																																					$ 302,254				$ (1,060,085)	433,829
Stock options granted | $ / shares
Unit placement assigned value | $
Antidilutive securities excluded from computation of earnings per share amount																																										96,006,372	96,006,372			120,808,982	120,808,982
2017 Stock Option Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock options granted																															15,650,000
Options exercisable price | $ / shares																															$ 0.13
Stock option granted terms																																		Stock options granted are subject to a maximum term of 5 years. All options granted shall vest immediately, except for those options granted to persons performing investor relations activities for the Company
2017 Stock Option Plan [Member] | Exercisable at Five Years [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock options exercisable																															9,500,000
2017 Stock Option Plan [Member] | Exercisable at Two Years [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock options exercisable																															6,150,000
2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock options granted	9,092,368	500,000		500,000			250,000			1,450,000	21,700,000
Options exercisable price | $ / shares		$ 0.40		$ 0.40			$ 0.58			$ 0.50	$ 0.70
Maximum number of common shares available																																																					27,312,368
Options exercisable period		5 years		5 years			5 years			5 years	5 years
Class A Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise of warrants price per share | $ / shares			$ 0.13		$ 0.13	$ 0.13			$ 0.13																										$ 0.13
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			500,000			500,000			500,000																										1,000,000
Class B Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Payments of stock issuance costs | $					$ 1,361
Exercise of warrants price per share | $ / shares			$ 0.19		$ 0.19	$ 0.19			$ 0.19																										$ 0.19
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			500,000		500,000	500,000			500,000																										1,000,000
Equity Option [Member]
Subsidiary, Sale of Stock [Line Items]
Number of stock options granted																																					750,000	750,000								2,630,000	2,630,000
Options exercisable price | $ / shares																																																$ 0.05
Proceeds from stock options erercised																																					$ 29,715	$ 37,500								$ 140,734	$ 175,800
Proceeds from other equity | $																																					$ 22,203									$ 121,932
Stock options granted | $ / shares																																											$ 0.37		$ 0.09
Equipment [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																		1,538,461
Shares issued, price per share | $ / shares																																																						$ 0.24
Fair value of assets																		$ 305,832																																				$ 369,231
July 2020 Convertible Debenture [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																					1,360,959
Shares issued, price per share | $ / shares																																																											$ 0.15
Convertiable common shares																					263,973
Conversion of stock value | $																					$ 26,286
Common stock, shares issued																					1,360,959
Common stock, value, issued | $																					$ 26,286
Principal amount																																																										$ 112,124	$ 150,000
June 2021 Convertible Debentures [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued during period, shares, conversion of units			1,000,000		1,000,000	1,000,000			1,000,000																										2,000,000
Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights																																																							33,000,000
Maximum [Member] | 2017 Stock Option Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Percentage of authorized grant stock options																																		20.00%
Maximum [Member] | 2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Maximum number of common shares available	33,292,368																																				33,292,368					33,292,368
Number of stock options forfeited																																														29,042,368	29,042,368
Maximum [Member] | Director and Officers [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, value, issued | $																																																												$ 5,000,000
Maximum [Member] | Equity Option [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercisable price | $ / shares																																																				$ 0.16
Minimum [Member] | 2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Maximum number of common shares available	5,980,000																																				5,980,000					5,980,000
Number of stock options forfeited																																														1,730,000	1,730,000
Minimum [Member] | Equity Option [Member]
Subsidiary, Sale of Stock [Line Items]
Options exercisable price | $ / shares																																																				0.05
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																																										1,375,499	1,375,499	25,724,955
Stock Issued During Period, Shares, Conversion of Convertible Securities			1,000,000		1,000,000	1,000,000			1,000,000																																	6,933,333	6,933,333
Proceeds from issuance of common stock																																				$ 2,899,295			$ 2,293,946
Warrants expired unexercised																																				15,389,448				15,389,448
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, shares issued																																														7,014,969
Proceeds from stock warrants erercised																																														$ 887,520	$ 1,120,130
Common stock warrants expired unexercised																																														525,173
Proceeds from other equity | $																																														$ 4,291
Warrants expired unexercised																																				2,428,363				2,428,363
Warrant [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise of warrants price per share | $ / shares																																																				0.21
Warrant [Member] | Minimum [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise of warrants price per share | $ / shares																																																				$ 0.05
Common Stock One [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued, price per share | $ / shares																																				$ 0.19				$ 0.19
Class of Warrant or Right, Number of Securities Called by Warrants or Rights																																				15,159,448				15,159,448
Proceeds from issuance of common stock																																							2,279,136	$ 2,880,295
Common Stock Two [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued, price per share | $ / shares																																																0.05
Class of Warrant or Right, Number of Securities Called by Warrants or Rights																																				200,000				200,000
Proceeds from issuance of common stock																																								$ 10,000		$ 7,830
Common Stock Three [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued, price per share | $ / shares																																				$ 0.30				$ 0.30
Class of Warrant or Right, Number of Securities Called by Warrants or Rights																																				30,000				30,000
Proceeds from issuance of common stock																																							$ 6,981	$ 9,000
Common Stock Purchase Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																																					929,005	929,005
Shares issued, price per share | $ / shares																																																0.19
Common stock warrants expired unexercised	3,191,933																																				3,191,933					3,191,933
Proceeds from issuance of common stock																																					$ 929,005	$ 1,177,755
Common stock broker warrants expired unexercised	40,000																																				40,000					40,000
Common Stock Purchase Warrant One [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																																					2,082,025	2,082,025
Shares issued, price per share | $ / shares																																																0.05
Proceeds from issuance of common stock																																					$ 81,354	$ 104,101
Common Stock Purchase Warrant Two [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																																					30,960	30,960
Shares issued, price per share | $ / shares																																																0.30
Proceeds from issuance of common stock																																					$ 7,357	$ 9,288
Non Brokered Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares												3,827,601	3,827,601	4,350,000	4,350,000																											25,724,955	25,724,955
Shares issued, price per share | $ / shares													$ 0.55		$ 0.20							$ 0.13																										0.13
Proceeds from issuance of private placement												$ 1,683,336	$ 2,105,180	$ 690,860	$ 870,000																											$ 2,621,314	$ 3,344,244
Issuance of shares, description												Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 for a period of eighteen months from the date of closing	Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 for a period of eighteen months from the date of closing	Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing	Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing
Payments of stock issuance costs | $												$ 124,923		$ 48,319																												$ 195,614
Non Brokered Private Placement [Member] | Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance of private placement | $																						$ 3,000,000
Non Brokered Private Placement [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																			5,223,420	5,223,420												5,599,171	5,599,171
Shares issued, price per share | $ / shares																				$ 0.13													$ 0.13
Proceeds from issuance of private placement																			$ 561,844	$ 679,044												$ 556,876	$ 727,892
Non Brokered Private Placement [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																													7,337,914	7,337,914
Shares issued, price per share | $ / shares																																																								$ 0.13
Proceeds from issuance of private placement																													$ 749,435	$ 953,930
Common stock shares subscriptions | $																													$ 39,996
Non Brokered Private Placement [Member] | Share-Based Payment Arrangement, Tranche Three [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																											5,382,303	5,382,303
Shares issued, price per share | $ / shares																												$ 0.13
Proceeds from issuance of private placement																											$ 547,496	$ 699,699
Non Brokered Private Placement [Member] | Share Based Compensation Award Tranche Four [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																									6,554,172	6,554,172
Shares issued, price per share | $ / shares																										$ 0.13
Proceeds from issuance of private placement																									$ 678,270	$ 852,042
Non Brokered Private Placement [Member] | Share Based Compensation Award Tranche Five and Final [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																							851,395	851,395
Shares issued, price per share | $ / shares																								$ 0.13
Proceeds from issuance of private placement																							$ 89,237	$ 110,681
Non Brokered Private Placement [Member] | Share Based Compensation Award Tranche Two and Final [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																17,853,506	17,853,506
Shares issued, price per share | $ / shares																	$ 0.13
Proceeds from issuance of private placement																$ 1,880,687	$ 2,320,956
Non Brokered Private Placement One [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares																																										23,076,926	23,076,926
Shares issued, price per share | $ / shares																																																$ 0.13
Proceeds from issuance of private placement																																										$ 2,442,531	$ 3,000,000
Issuance of shares, description																																										Each unit issued consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective financing tranche	Each unit issued consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective financing tranche
Payments of stock issuance costs | $																																										$ 154,336
Non Brokered Private Placement One [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Issuance of shares, description																																										Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche	Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche
Private Placement [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued pursuant to private placements [note 13[b]], shares								1,375,499
Shares issued, price per share | $ / shares								$ 0.55
Proceeds from issuance of private placement | $								$ 756,524
Payments of stock issuance costs | $								$ 26,656
Share Price | $ / shares								$ 0.75

SCHEDULE OF CLASSIFICATION OF F

SCHEDULE OF CLASSIFICATION OF FINANCIAL INSTRUMENTS (Details) - USD ($)	Apr. 30, 2022	Oct. 31, 2021
Fair Value Disclosures [Abstract]
Cash	$ 774,409
Other receivables	50,765
Subscription receivable	185,000
Deposits held by related parties	388,757
Accounts payable and accrued liabilities	2,715,924
Due to related parties	1,253,280
Convertible debenture, net	1,783,584
Warrant liability	$ 2,468,261

SCHEDULE OF FOREIGN CURRENCY RI

SCHEDULE OF FOREIGN CURRENCY RISK (Details)	Apr. 30, 2022CAD ($)
Total	$ (2,003,641)
Cash [Member]
Total	208,683
Other Receivable [Member]
Total	64,930
Accounts Payable and Accrued Liabilities [Member]
Total	(1,511,845)
Due To Related Parties [Member]
Total	$ (765,409)

FINANCIAL INSTRUMENTS AND FIN_3

FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Details Narrative) - USD ($)	6 Months Ended
	Apr. 30, 2022	Oct. 31, 2021
Fair Value Disclosures [Abstract]
Cash	$ 774,409	$ 462,360
Short term investments	0	0
Foreign currency risk rate
Increase decrease in foreign currency transaction amount	78,312
Working capital deficit	$ 7,172,573	$ 9,657,316

SCHEDULE OF ASSETS INFORMATION

SCHEDULE OF ASSETS INFORMATION (Details) - USD ($)	Apr. 30, 2022	Oct. 31, 2021	Oct. 31, 2020
Revenues from External Customers and Long-Lived Assets [Line Items]
United States – property, plant and equipment	$ 3,977,619	$ 2,574,704	$ 79,436
United States – mineral property costs	93,453	93,453
Property, plant and equipment net	4,071,072	2,668,157
Other assets	2,004,431	1,845,355
Total Assets	6,075,503	4,513,512
CANADA
Revenues from External Customers and Long-Lived Assets [Line Items]
United States – property, plant and equipment	3,946,315	2,546,383
Other assets	392,853	1,554,827
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
United States – property, plant and equipment	31,304	28,321
United States – mineral property costs	93,453	93,453
Other assets	$ 1,611,578	$ 290,528

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative)	Jun. 08, 2022$ / sharesshares	Jun. 03, 2022USD ($)$ / sharesshares	May 09, 2022USD ($)$ / sharesshares	Aug. 11, 2021USD ($)shares	Aug. 11, 2021CAD ($)$ / sharesshares	Jul. 16, 2021USD ($)shares	Jul. 16, 2021CAD ($)$ / sharesshares	May 28, 2021USD ($)shares	May 28, 2021CAD ($)$ / sharesshares	Nov. 20, 2020USD ($)shares	Nov. 20, 2020CAD ($)$ / sharesshares	Jun. 13, 2022CAD ($)$ / sharesshares	Jan. 31, 2022CAD ($)$ / sharesshares	Jan. 31, 2022USD ($)	Jan. 31, 2022CAD ($)$ / sharesshares	Apr. 30, 2022USD ($)$ / sharesshares	Apr. 30, 2022CAD ($)shares	Apr. 30, 2021USD ($)shares	Apr. 30, 2022$ / sharesshares	Apr. 22, 2022$ / shares	Nov. 03, 2021$ / shares	May 05, 2021$ / shares
Subsequent Event [Line Items]
Number of shares issued price per share | $ / shares																					$ 0.65
Proceeds from issuance of common stock | $																$ 3,851,614		$ 1,856,336
Warrants exercisable price | $ / shares																				$ 0.20
June 2021 Convertible Debenture [Member]
Subsequent Event [Line Items]
Number of shares issued price per share | $ / shares																$ 1
Number of shares issued																6,000,000	6,000,000
June 2021 Convertible Debenture [Member] | Common Class A [Member]
Subsequent Event [Line Items]
Number of warrants exercisable																3,000,000			3,000,000
Warrants exercisable price | $ / shares																$ 0.13
June 2021 Convertible Debenture [Member] | Common Class B [Member]
Subsequent Event [Line Items]
Number of warrants exercisable																3,000,000			3,000,000
Warrants exercisable price | $ / shares																$ 0.19
Non Brokered Private Placement [Member]
Subsequent Event [Line Items]
Number of shares issued price per share | $ / shares					$ 0.55		$ 0.20												$ 0.13			$ 0.13
Number of shares issued				3,827,601	3,827,601	4,350,000	4,350,000									25,724,955	25,724,955
Proceeds from Issuance of Private Placement				$ 1,683,336	$ 2,105,180	$ 690,860	$ 870,000									$ 2,621,314	$ 3,344,244
Issuance of shares description				Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 for a period of eighteen months from the date of closing	Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.65 for a period of eighteen months from the date of closing	Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing	Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.30 for a period of one year from the date of closing
Non Brokered Private Placement [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Subsequent Event [Line Items]
Number of shares issued price per share | $ / shares									$ 0.13		$ 0.13
Number of shares issued								5,223,420	5,223,420	5,599,171	5,599,171
Proceeds from Issuance of Private Placement								$ 561,844	$ 679,044	$ 556,876	$ 727,892
Non Brokered Private Placement One [Member]
Subsequent Event [Line Items]
Number of shares issued price per share | $ / shares																			0.13
Number of shares issued																23,076,926	23,076,926
Proceeds from Issuance of Private Placement																$ 2,442,531	$ 3,000,000
Issuance of shares description																Each unit issued consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective financing tranche	Each unit issued consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of CA$0.19 for a period of one year from the date of closing of the respective financing tranche
Subsequent Event [Member] | June 2021 Convertible Debenture [Member]
Subsequent Event [Line Items]
Number of shares issued	1,000,000
Subsequent Event [Member] | June 2021 Convertible Debenture [Member] | Common Class A [Member]
Subsequent Event [Line Items]
Number of warrants exercisable	500,000
Warrants exercisable price | $ / shares	$ 0.13
Subsequent Event [Member] | June 2021 Convertible Debenture [Member] | Common Class B [Member]
Subsequent Event [Line Items]
Number of warrants exercisable	500,000
Warrants exercisable price | $ / shares	$ 0.19
Subsequent Event [Member] | Non Brokered Private Placement [Member]
Subsequent Event [Line Items]
Number of shares issued		2,467,000
Proceeds from Issuance of Private Placement | $		$ 616,750
Subsequent Event [Member] | Non Brokered Private Placement [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Subsequent Event [Line Items]
Number of shares issued price per share | $ / shares			$ 0.25
Number of shares issued			1,727,000
Proceeds from Issuance of Private Placement | $			$ 431,750
Subsequent Event [Member] | Non Brokered Private Placement [Member] | Share Based Compensation Award Second and Final Tranche [Member]
Subsequent Event [Line Items]
Number of shares issued price per share | $ / shares		$ 0.25
Number of shares issued		740,000
Proceeds from Issuance of Private Placement | $		$ 185,000
Subsequent Event [Member] | Non Brokered Private Placement One [Member]
Subsequent Event [Line Items]
Issuance of shares description			Each unit consists of one common share and one common share purchase warrant entitling the holder thereof to acquire a further common share at a price of $0.45 for a period of one year from the date of closing
Common Stock [Member]
Subsequent Event [Line Items]
Proceeds from issuance of common stock													$ 2,899,295	$ 2,293,946
Warrants shares													15,389,448		15,389,448
Number of shares issued																1,375,499	1,375,499	25,724,955
Common Stock [Member] | June 2021 Convertible Debenture [Member]
Subsequent Event [Line Items]
Number of shares issued																6,000,000	6,000,000
Common Stock [Member] | Non Brokered Private Placement One [Member]
Subsequent Event [Line Items]
Issuance of shares description																Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche	Each unit issued consists of one common share and one common share purchase warrant entitling the holder to acquire a further common share at a price of CA$0.19 for a period of one year from the closing date of the respective financing tranche
Common Stock [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Number of warrants exercisable												3,793,331
Number of shares issued price per share | $ / shares												$ 0.19
Proceeds from issuance of common stock | $												$ 720,733
Common stock broker warrants expired unexercised												13,725
Common Stock [Member] | Subsequent Event [Member] | June 2021 Convertible Debenture [Member]
Subsequent Event [Line Items]
Number of shares issued	1,000,000
Common Stock One [Member]
Subsequent Event [Line Items]
Number of warrants exercisable													15,159,448		15,159,448
Number of shares issued price per share | $ / shares													$ 0.19		$ 0.19
Proceeds from issuance of common stock														2,279,136	$ 2,880,295
Common Stock One [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Number of warrants exercisable												800,000
Number of shares issued price per share | $ / shares												$ 0.05
Proceeds from issuance of common stock | $												$ 40,000
Warrant [Member]
Subsequent Event [Line Items]
Warrants shares													2,428,363		2,428,363
Warrant [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Warrants shares												1,153,414
Common Stock Two [Member]
Subsequent Event [Line Items]
Number of warrants exercisable													200,000		200,000
Number of shares issued price per share | $ / shares																			$ 0.05
Proceeds from issuance of common stock															$ 10,000	$ 7,830
Common Stock Two [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Number of warrants exercisable												300,000
Number of shares issued price per share | $ / shares												$ 0.05
Proceeds from issuance of common stock | $												$ 15,000
Common Stock Three [Member]
Subsequent Event [Line Items]
Number of warrants exercisable													30,000		30,000
Number of shares issued price per share | $ / shares													$ 0.30		$ 0.30
Proceeds from issuance of common stock														$ 6,981	$ 9,000
Common Stock Three [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Number of warrants exercisable												250,000
Number of shares issued price per share | $ / shares												$ 0.13
Proceeds from issuance of common stock | $												$ 32,500